502 
(1) INITIAL REPORT.—The initial report under 
subsection (a) shall address all requests described in 
such subsection made during the period— 
(A) beginning on January 31, 2020; and 
(B) ending on the date that is 30 days be-
fore the date of submission of the report. 
(2) UPDATES.—Each update to the report 
under subsection (a) shall address all requests de-
scribed in such subsection made during the period— 
(A) beginning at the end of the previous 
reporting period under this section; and 
(B) ending on the date that is 30 days be-
fore the date of submission of the updated re-
port. 
(c) CONTENTS OF REPORT.—The report under sub-
section (a) (and updates thereto) shall include— 
(1) the details of each request described in such 
subsection, including— 
(A) the specific medical countermeasures, 
including devices such as personal protective 
equipment, and other materials requested; and 
(B) the amount of such materials re-
quested; and 
(2) the outcomes of each request described in 
subsection (a), including—
503 
(A) whether the request was wholly ful-
filled, partially fulfilled, or denied; 
(B) if the request was wholly or partially 
fulfilled, the fulfillment amount; and 
(C) if the request was partially fulfilled or 
denied, a rationale for such outcome. 
SEC. 30535. IMPROVED, TRANSPARENT PROCESSES FOR 
THE STRATEGIC NATIONAL STOCKPILE. 
(a) IN GENERAL.—Not later than January 1, 2021, 
the Secretary, in collaboration with the Assistant Sec-
retary for Preparedness and Response and the Director 
of the Centers for Disease Control and Prevention, shall 
develop and implement improved, transparent processes 
for the use and distribution of drugs, vaccines and other 
biological products, medical devices, and other supplies 
(including personal protective equipment, ancillary med-
ical supplies, and other applicable supplies required for the 
administration of drugs, vaccines and other biological 
products, diagnostic tests, and other medical devices ) in 
the Strategic National Stockpile under section 319F–2 of 
the Public Health Service Act (42 U.S.C. 247d–6b) (in 
this section referred to as the ‘‘Stockpile’’). 
(b) PROCESSES.—The processes developed under 
subsection (a) shall include—
504 
(1) the form and manner in which States, local-
ities, Tribes, and territories are required to submit 
requests for supplies from the Stockpile; 
(2) the criteria used by the Secretary in re-
sponding to such requests, including the reasons for 
fulfilling or denying such requests; 
(3) what circumstances result in prioritization 
of distribution of supplies from the Stockpile to 
States, localities, Tribes, or territories; 
(4) clear plans for future, urgent communica-
tion between the Secretary and States, localities, 
Tribes, and territories regarding the outcome of 
such requests; and 
(5) any differences in the processes developed 
under subsection (a) for geographically related emer-
gencies, such as weather events, and national emer-
gencies, such as pandemics. 
(c) REPORT TO CONGRESS.—Not later than January 
1, 2021, the Secretary shall— 
(1) submit a report to the Committee Energy 
and Commerce of the House of Representatives and 
the Committee on Health, Education, Labor and 
Pensions of the Senate regarding the improved, 
transparent processes developed under this section; 
and
505 
(2) include in such report recommendations for 
opportunities for communication (by telebriefing, 
phone calls, or in-person meetings) between the Sec-
retary and States, localities, Tribes, and territories 
regarding such improved, transparent processes. 
SEC. 30536. GAO STUDY ON THE FEASIBILITY AND BENE-
FITS OF A STRATEGIC NATIONAL STOCKPILE 
USER FEE AGREEMENT. 
(a) IN GENERAL.— The Comptroller General of the 
United States shall conduct a study to investigate the fea-
sibility of establishing user fees to offset certain Federal 
costs attributable to the procurement of single-source ma-
terials for the Strategic National Stockpile under section 
319F–2 of the Public Health Service Act (42 U.S.C. 
247d–6b) and distributions of such materials from the 
Stockpile. In conducting this study, the Comptroller Gen-
eral shall consider, to the extent information is available— 
(1) whether entities receiving such distributions 
generate profits from those distributions; 
(2) any Federal costs attributable to such dis-
tributions; 
(3) whether such user fees would provide the 
Secretary with funding to potentially offset procure-
ment costs of such materials for the Strategic Na-
tional Stockpile; and
506 
(4) any other issues the Comptroller General 
identifies as relevant. 
(b) REPORT.—Not later than February 1, 2023, the 
Comptroller General of the United States shall submit to 
the Congress a report on the findings and conclusions of 
the study under subsection (a). 
Subtitle C—Testing and Testing 
Infrastructure Improvements 
SEC. 30541. COVID–19 TESTING STRATEGY. 
(a) STRATEGY.—Not later than June 15, 2020, the 
Secretary shall update the COVID–19 strategic testing 
plan under the heading ‘‘Department of Health and 
Human Services—Office of the Secretary—Public Health 
and Social Service Emergency Fund’’ in title I of division 
B of the Paycheck Protection Program and Health Care 
Enhancement Act (Public Law 116–139, 134 Stat. 620, 
626–627) and submit to the appropriate congressional 
committees such updated national plan identifying— 
(1) what level of, types of, and approaches to 
testing (including predicted numbers of tests, popu-
lations to be tested, and frequency of testing and the 
appropriate setting whether a health care setting 
(such as hospital-based, high-complexity laboratory, 
point-of-care, mobile testing units, pharmacies or 
community health centers) or non-health care setting
507 
(such as workplaces, schools, or child care centers)) 
are necessary— 
(A) to sufficiently monitor and contribute 
to the control of the transmission of SARS– 
CoV–2 in the United States; 
(B) to ensure that any reduction in social 
distancing efforts, when determined appropriate 
by public health officials, can be undertaken in 
a manner that optimizes the health and safety 
of the people of the United States, and reduces 
disparities (including disparities related to race, 
ethnicity, sex, age, disability status, socio-
economic status, and geographic location) in the 
prevalence of, incidence of, and health outcomes 
with respect to, COVID–19; and 
(C) to provide for ongoing surveillance suf-
ficient to support contact tracing, case identi-
fication, quarantine, and isolation to prevent fu-
ture outbreaks of COVID–19; 
(2) specific plans and benchmarks, each with 
clear timelines, to ensure— 
(A) such level of, types of, and approaches 
to testing as are described in paragraph (1), 
with respect to optimizing health and safety;
508 
(B) sufficient availability of all necessary 
testing materials and supplies, including extrac-
tion and testing kits, reagents, transport media, 
swabs, instruments, analysis equipment, per-
sonal protective equipment if necessary for test-
ing (including point-of-care testing), and other 
equipment; 
(C) allocation of testing materials and sup-
plies in a manner that optimizes public health, 
including by considering the variable impact of 
SARS–CoV–2 on specific States, territories, In-
dian Tribes, Tribal organizations, urban Indian 
organizations, communities, industries, and pro-
fessions; 
(D) sufficient evidence of validation for 
tests that are deployed as a part of such strat-
egy; 
(E) sufficient laboratory and analytical ca-
pacity, including target turnaround time for 
test results; 
(F) sufficient personnel, including per-
sonnel to collect testing samples, conduct and 
analyze results, and conduct testing follow-up, 
including contact tracing, as appropriate; and
509 
(G) enforcement of the Families First 
Coronavirus Response Act (Public Law 116– 
127) to ensure patients who are tested are not 
subject to cost sharing; 
(3) specific plans to ensure adequate testing in 
rural areas, frontier areas, health professional short-
age areas, and medically underserved areas (as de-
fined in section 330I(a) of the Public Health Service 
Act (42 U.S.C. 254c–14(a))), and for underserved 
populations, Native Americans (including Indian 
Tribes, Tribal organizations, and urban Indian orga-
nizations), and populations at increased risk related 
to COVID–19; 
(4) specific plans to ensure accessibility of test-
ing to people with disabilities, older individuals, and 
individuals with underlying health conditions or 
weakened immune systems; and 
(5) specific plans for broadly developing and 
implementing testing for potential immunity in the 
United States, as appropriate, in a manner suffi-
cient— 
(A) to monitor and contribute to the con-
trol of SARS–CoV–2 in the United States; 
(B) to ensure that any reduction in social 
distancing efforts, when determined appropriate
510 
by public health officials, can be undertaken in 
a manner that optimizes the health and safety 
of the people of the United States; and 
(C) to reduce disparities (including dispari-
ties related to race, ethnicity, sex, age, dis-
ability status, socioeconomic status, and geo-
graphic location) in the prevalence of, incidence 
of, and health outcomes with respect to, 
COVID–19. 
(b) COORDINATION.—The Secretary shall carry out 
this section— 
(1) in coordination with the Administrator of 
the Federal Emergency Management Agency; 
(2) in collaboration with other agencies and de-
partments, as appropriate; and 
(3) taking into consideration the State plans for 
COVID–19 testing prepared as required under the 
heading ‘‘Department of Health and Human Serv-
ices—Office of the Secretary—Public Health and 
Social Service Emergency Fund’’ in title I of divi-
sion B of the Paycheck Protection Program and 
Health Care Enhancement Act (Public Law 116– 
139; 134 Stat. 620, 624). 
(c) UPDATES.—
511 
(1) FREQUENCY.—The updated national plan 
under subsection (a) shall be updated every 30 days 
until the end of the public health emergency first de-
clared by the Secretary under section 319 of the 
Public Health Service Act (42 U.S.C. 247d) on Jan-
uary 31, 2020, with respect to COVID–19. 
(2) RELATION TO OTHER LAW.—Paragraph (1) 
applies in lieu of the requirement (for updates every 
90 days until funds are expended) in the second to 
last proviso under the heading ‘‘Department of 
Health and Human Services—Office of the Sec-
retary—Public Health and Social Service Emergency 
Fund’’ in title I of division B of the Paycheck Pro-
tection Program and Health Care Enhancement Act 
(Public Law 116–139; 134 Stat. 620, 627). 
(d) APPROPRIATE CONGRESSIONAL COMMITTEES.— 
In this section, the term ‘‘appropriate congressional com-
mittees’’ means— 
(1) the Committee on Appropriations and the 
Committee on Energy and Commerce of the House 
of Representatives; and 
(2) the Committee on Appropriations and the 
Committee on Health, Education, Labor and Pen-
sions and of the Senate.
512 
SEC. 
30542. 
CENTRALIZED 
TESTING 
INFORMATION 
WEBSITE. 
The Secretary shall establish and maintain a public, 
searchable webpage, to be updated and corrected as nec-
essary through a process established by the Secretary, on 
the website of the Department of Health and Human 
Services that— 
(1) identifies all in vitro diagnostic and sero-
logical tests used in the United States to analyze 
clinical specimens for detection of SARS–CoV–2 or 
antibodies specific to SARS–CoV–2, including— 
(A) those tests— 
(i) that are approved, cleared, or au-
thorized under section 510(k), 513, 515, or 
564 of the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 360(k), 360c, 360e, 
360bbb–3); 
(ii) that have been validated by the 
test’s developers for use on clinical speci-
mens and for which the developer has noti-
fied the Food and Drug Administration of 
the developer’s intent to market the test 
consistent with applicable guidance issued 
by the Secretary; or 
(iii) that have been developed and au-
thorized by a State that has notified the
515 
SEC. 30543. MANUFACTURER REPORTING OF TEST DIS-
TRIBUTION. 
(a) IN GENERAL.—A commercial manufacturer of an 
in vitro diagnostic or serological COVID–19 test shall, on 
a weekly basis, submit a notification to the Secretary re-
garding distribution of each such test, which notifica-
tion— 
(1) shall include the number of tests distributed 
and the entities to which the tests are distributed; 
and 
(2) may include the quantity of such tests dis-
tributed by the manufacturer. 
(b) CONFIDENTIALITY.—Nothing in this section shall 
be construed as authorizing the Secretary to disclose any 
information that is a trade secret or confidential informa-
tion subject to section 552(b)(4) of title 5, United States 
Code, or section 1905 of title 18, United States Code. 
(c) FAILURE TO MEET REQUIREMENTS.—If a manu-
facturer fails to submit a notification as required under 
subsection (a), the following applies: 
(1) The Secretary shall issue a letter to such 
manufacturer informing such manufacturer of such 
failure. 
(2) Not later than 7 calendar days after the 
issuance of a letter under paragraph (1), the manu-
516 
facturer to whom such letter is issued shall submit 
to the Secretary a written response to such letter— 
(A) setting forth the basis for noncompli-
ance; and 
(B) providing information as required 
under subsection (a). 
(3) Not later than 14 calendar days after the 
issuance of a letter under paragraph (1), the Sec-
retary shall make such letter and any response to 
such letter under paragraph (2) available to the pub-
lic on the internet website of the Food and Drug Ad-
ministration, with appropriate redactions made to 
protect information described in subsection (b). The 
preceding sentence shall not apply if the Secretary 
determines that— 
(A) the letter under paragraph (1) was 
issued in error; or 
(B) after review of such response, the 
manufacturer had a reasonable basis for not 
notifying as required under subsection (a). 
SEC. 30544. STATE TESTING REPORT. 
For any State that authorizes (or intends to author-
ize) one or more laboratories in the State to develop and 
perform in vitro diagnostic COVID–19 tests, the head of
517 
the department or agency of such State with primary re-
sponsibility for health shall— 
(1) notify the Secretary of such authorization 
(or intention to authorize); and 
(2) provide the Secretary with a weekly re-
port— 
(A) identifying all laboratories authorized 
(or intended to be authorized) by the State to 
develop 
and 
perform 
in 
vitro 
diagnostic 
COVID–19 tests; 
(B) including relevant information on all 
laboratories identified pursuant to subpara-
graph (A), which may include information on 
laboratory testing capacity; 
(C) identifying all in vitro diagnostic 
COVID–19 tests developed and approved for 
clinical use in laboratories identified pursuant 
to subparagraph (A); and 
(D) including relevant information on all 
tests identified pursuant to subparagraph (C), 
which may include— 
(i) the name and contact information 
of the developer of any such test; 
(ii) any fact sheets, manufacturer in-
structions, and package inserts for any
518 
such test, including information on in-
tended use; and 
(iii) the sensitivity and specificity of 
any such test. 
SEC. 30545. STATE LISTING OF TESTING SITES. 
Not later than 14 days after the date of enactment 
of this Act, any State receiving funding or assistance 
under this Act, as a condition on such receipt, shall estab-
lish and maintain a public, searchable webpage on the offi-
cial website of the State that— 
(1) identifies all sites located in the State that 
provide diagnostic or serological testing for SARS– 
CoV–2; and 
(2) provides appropriate contact information for 
SARS–CoV–2 testing sites pursuant to paragraph 
(1). 
SEC. 30546. REPORTING OF COVID–19 TESTING RESULTS. 
(a) IN GENERAL.—Every laboratory that performs or 
analyzes a test that is intended to detect SARS–CoV–2 
or to diagnose a possible case of COVID–19 shall report 
daily the number of tests performed and the results from 
each such test to the Secretary of Health and Human 
Services and to the Secretary of Homeland Security, in 
such form and manner as such Secretaries may prescribe. 
Such information shall be made available to the public in
519 
a searchable, electronic format as soon as is practicable, 
and in no case later than one week after such information 
is received. 
(b) ADDITIONAL REPORTING REQUIREMENTS.—The 
Secretaries specified in subsection (a)— 
(1) may specify additional reporting require-
ments under this section by regulation, including by 
interim final rule, or by guidance; and 
(2) may issue such regulations or guidance 
without regard to the procedures otherwise required 
by section 553 of title 5, United States Code. 
SEC. 30547. GAO REPORT ON DIAGNOSTIC TESTS. 
(a) GAO STUDY.—Not later than 18 months after 
the date of enactment of this Act, the Comptroller General 
of the United States shall submit to the Committee on 
Energy and Commerce of the House of Representatives 
and the Committee on Health, Education, Labor and Pen-
sions of the Senate a report describing the response of 
entities described in subsection (b) to the COVID–19 pan-
demic with respect to the development, regulatory evalua-
tion, and deployment of diagnostic tests. 
(b) ENTITIES DESCRIBED.—Entities described in 
this subsection include— 
(1) laboratories, including public health, aca-
demic, clinical, and commercial laboratories;
520 
(2) diagnostic test manufacturers; 
(3) State, local, Tribal, and territorial govern-
ments; and 
(4) the Food and Drug Administration, the 
Centers for Disease Control and Prevention, the 
Centers for Medicare & Medicaid Services, the Na-
tional Institutes of Health, and other relevant Fed-
eral agencies, as appropriate. 
(c) CONTENTS.—The report under subsection (a) 
shall include— 
(1) a description of actions taken by entities de-
scribed in subsection (b) to develop, evaluate, and 
deploy diagnostic tests; 
(2) an assessment of the coordination of Fed-
eral agencies in the development, regulatory evalua-
tion, and deployment of diagnostic tests; 
(3) an assessment of the standards used by the 
Food and Drug Administration to evaluate diag-
nostic tests; 
(4) an assessment of the clarity of Federal 
agency guidance related to testing, including the 
ability for individuals without medical training to 
understand which diagnostic tests had been evalu-
ated by the Food and Drug Administration; 
(5) a description of—
522 
(3) the detection of antibodies specific to 
SARS–CoV–2, such as a serological test. 
SEC. 
30548. 
PUBLIC 
HEALTH 
DATA 
SYSTEM 
TRANS-
FORMATION. 
Subtitle C of title XXVIII of the Public Health Serv-
ice Act (42 U.S.C. 300hh–31 et seq.) is amended by add-
ing at the end the following: 
‘‘SEC. 
2822. 
PUBLIC 
HEALTH 
DATA 
SYSTEM 
TRANS-
FORMATION. 
‘‘(a) EXPANDING CDC AND PUBLIC HEALTH DE-
PARTMENT CAPABILITIES.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall— 
‘‘(A) conduct activities to expand, enhance, 
and improve applicable public health data sys-
tems used by the Centers for Disease Control 
and Prevention, related to the interoperability 
and improvement of such systems (including as 
it relates to preparedness for, prevention and 
detection of, and response to public health 
emergencies); and 
‘‘(B) award grants or cooperative agree-
ments to State, local, Tribal, or territorial pub-
lic health departments for the expansion and
523 
modernization of public health data systems, to 
assist public health departments in— 
‘‘(i) assessing current data infrastruc-
ture capabilities and gaps to improve and 
increase consistency in data collection, 
storage, and analysis and, as appropriate, 
to improve dissemination of public health- 
related information; 
‘‘(ii) improving secure public health 
data collection, transmission, exchange, 
maintenance, and analysis; 
‘‘(iii) improving the secure exchange 
of data between the Centers for Disease 
Control and Prevention, State, local, Trib-
al, and territorial public health depart-
ments, public health organizations, and 
health care providers, including by public 
health officials in multiple jurisdictions 
within such State, as appropriate, and by 
simplifying and supporting reporting by 
health care providers, as applicable, pursu-
ant to State law, including through the use 
of health information technology; 
‘‘(iv) enhancing the interoperability of 
public health data systems (including sys-
524 
tems created or accessed by public health 
departments) with health information tech-
nology, including with health information 
technology 
certified 
under 
section 
3001(c)(5); 
‘‘(v) supporting and training data sys-
tems, data science, and informatics per-
sonnel; 
‘‘(vi) supporting earlier disease and 
health condition detection, such as through 
near real-time data monitoring, to support 
rapid public health responses; 
‘‘(vii) supporting activities within the 
applicable jurisdiction related to the expan-
sion and modernization of electronic case 
reporting; and 
‘‘(viii) developing and disseminating 
information related to the use and impor-
tance of public health data. 
‘‘(2) DATA STANDARDS.—In carrying out para-
graph (1), the Secretary, acting through the Direc-
tor of the Centers for Disease Control and Preven-
tion, shall, as appropriate and in consultation with 
the Office of the National Coordinator for Health 
Information Technology, designate data and tech-
525 
nology standards (including standards for interoper-
ability) for public health data systems, with def-
erence given to standards published by consensus- 
based standards development organizations with 
public input and voluntary consensus-based stand-
ards bodies. 
‘‘(3) 
PUBLIC-PRIVATE
PARTNERSHIPS.—The 
Secretary may develop and utilize public-private 
partnerships for technical assistance, training, and 
related implementation support for State, local, 
Tribal, and territorial public health departments, 
and the Centers for Disease Control and Prevention, 
on the expansion and modernization of electronic 
case reporting and public health data systems, as 
applicable. 
‘‘(b) REQUIREMENTS.— 
‘‘(1) 
HEALTH
INFORMATION
TECHNOLOGY 
STANDARDS.—The Secretary may not award a grant 
or cooperative agreement under subsection (a)(1)(B) 
unless the applicant uses or agrees to use standards 
endorsed by the National Coordinator for Health In-
formation 
Technology 
pursuant 
to 
section 
3001(c)(1) or adopted by the Secretary under sec-
tion 3004.
526 
‘‘(2) WAIVER.—The Secretary may waive the 
requirement under paragraph (1) with respect to an 
applicant if the Secretary determines that the activi-
ties under subsection (a)(1)(B) cannot otherwise be 
carried out within the applicable jurisdiction. 
‘‘(3) APPLICATION.—A State, local, Tribal, or 
territorial health department applying for a grant or 
cooperative agreement under this section shall sub-
mit an application to the Secretary at such time and 
in such manner as the Secretary may require. Such 
application shall include information describing— 
‘‘(A) the activities that will be supported 
by the grant or cooperative agreement; and 
‘‘(B) how the modernization of the public 
health data systems involved will support or im-
pact the public health infrastructure of the 
health department, including a description of 
remaining gaps, if any, and the actions needed 
to address such gaps. 
‘‘(c) STRATEGY AND IMPLEMENTATION PLAN.—Not 
later than 180 days after the date of enactment of this 
section, the Secretary, acting through the Director of the 
Centers for Disease Control and Prevention, shall submit 
to the Committee on Health, Education, Labor and Pen-
sions of the Senate and the Committee on Energy and
527 
Commerce of the House of Representatives a coordinated 
strategy and an accompanying implementation plan that 
identifies and demonstrates the measures the Secretary 
will utilize to— 
‘‘(1) update and improve applicable public 
health data systems used by the Centers for Disease 
Control and Prevention; and 
‘‘(2) carry out the activities described in this 
section to support the improvement of State, local, 
Tribal, and territorial public health data systems. 
‘‘(d) 
CONSULTATION.—The 
Secretary, 
acting 
through the Director of the Centers for Disease Control 
and Prevention, shall consult with State, local, Tribal, and 
territorial health departments, professional medical and 
public health associations, associations representing hos-
pitals or other health care entities, health information 
technology experts, and other appropriate public or private 
entities regarding the plan and grant program to mod-
ernize public health data systems pursuant to this section. 
Activities under this subsection may include the provision 
of technical assistance and training related to the ex-
change of information by such public health data systems 
used by relevant health care and public health entities at 
the local, State, Federal, Tribal, and territorial levels, and 
the development and utilization of public-private partner-
528 
ships for implementation support applicable to this sec-
tion. 
‘‘(e) REPORT TO CONGRESS.—Not later than 1 year 
after the date of enactment of this section, the Secretary 
shall submit a report to the Committee on Health, Edu-
cation, Labor and Pensions of the Senate and the Com-
mittee on Energy and Commerce of the House of Rep-
resentatives that includes— 
‘‘(1) a description of any barriers to— 
‘‘(A) public health authorities imple-
menting interoperable public health data sys-
tems and electronic case reporting; 
‘‘(B) the exchange of information pursuant 
to electronic case reporting; or 
‘‘(C) reporting by health care providers 
using such public health data systems, as ap-
propriate, and pursuant to State law; 
‘‘(2) an assessment of the potential public 
health impact of implementing electronic case re-
porting and interoperable public health data sys-
tems; and 
‘‘(3) a description of the activities carried out 
pursuant to this section. 
‘‘(f) ELECTRONIC CASE REPORTING.—In this sec-
tion, the term ‘electronic case reporting’ means the auto-
529 
mated identification, generation, and bilateral exchange of 
reports of health events among electronic health record or 
health information technology systems and public health 
authorities. 
‘‘(g) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there are authorized to be appro-
priated $450,000,000 to remain available until ex-
pended.’’. 
SEC. 30549. PILOT PROGRAM TO IMPROVE LABORATORY IN-
FRASTRUCTURE. 
(a) IN GENERAL.—The Secretary shall award grants 
to States and political subdivisions of States to support 
the improvement, renovation, or modernization of infra-
structure at clinical laboratories (as defined in section 353 
of the Public Health Service Act (42 U.S.C. 263a)) that 
will help to improve SARS–CoV–2 and COVID–19 testing 
and response activities, including the expansion and en-
hancement of testing capacity at such laboratories. 
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$1,000,000,000 to remain available until expended.
530 
SEC. 30550. CORE PUBLIC HEALTH INFRASTRUCTURE FOR 
STATE, LOCAL, TRIBAL, AND TERRITORIAL 
HEALTH DEPARTMENTS. 
(a) PROGRAM.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall establish a core public health infrastructure 
program consisting of awarding grants under subsection 
(b). 
(b) GRANTS.— 
(1) AWARD.—For the purpose of addressing 
core public health infrastructure needs, the Sec-
retary— 
(A) shall award a grant to each State 
health department; and 
(B) may award grants on a competitive 
basis to State, local, Tribal, or territorial health 
departments. 
(2) ALLOCATION.—Of the total amount of 
funds awarded as grants under this subsection for a 
fiscal year— 
(A) not less than 50 percent shall be for 
grants to State health departments under para-
graph (1)(A); and 
(B) not less than 30 percent shall be for 
grants to State, local, Tribal, or territorial 
health departments under paragraph (1)(B).
531 
(c) USE OF FUNDS.—A State, local, Tribal, or terri-
torial health department receiving a grant under sub-
section (b) shall use the grant funds to address core public 
health infrastructure needs, including those identified in 
the accreditation process under subsection (g). 
(d) FORMULA GRANTS TO STATE HEALTH DEPART-
MENTS.—In making grants under subsection (b)(1)(A), 
the Secretary shall award funds to each State health de-
partment in accordance with— 
(1) a formula based on population size; burden 
of preventable disease and disability; and core public 
health infrastructure gaps, including those identified 
in the accreditation process under subsection (g); 
and 
(2) application requirements established by the 
Secretary, including a requirement that the State 
health department submit a plan that demonstrates 
to the satisfaction of the Secretary that the State’s 
health department will— 
(A) address its highest priority core public 
health infrastructure needs; and 
(B) as appropriate, allocate funds to local 
health departments within the State. 
(e) COMPETITIVE GRANTS TO STATE, LOCAL, TRIB-
AL, AND
TERRITORIAL
HEALTH
DEPARTMENTS.—In
532 
making grants under subsection (b)(1)(B), the Secretary 
shall give priority to applicants demonstrating core public 
health infrastructure needs identified in the accreditation 
process under subsection (g). 
(f) MAINTENANCE OF EFFORT.—The Secretary may 
award a grant to an entity under subsection (b) only if 
the entity demonstrates to the satisfaction of the Sec-
retary that— 
(1) funds received through the grant will be ex-
pended only to supplement, and not supplant, non- 
Federal and Federal funds otherwise available to the 
entity for the purpose of addressing core public 
health infrastructure needs; and 
(2) with respect to activities for which the grant 
is awarded, the entity will maintain expenditures of 
non-Federal amounts for such activities at a level 
not less than the level of such expenditures main-
tained by the entity for the fiscal year preceding the 
fiscal year for which the entity receives the grant. 
(g) ESTABLISHMENT OF A PUBLIC HEALTH ACCRED-
ITATION PROGRAM.— 
(1) IN GENERAL.—The Secretary shall— 
(A) develop, and periodically review and 
update, standards for voluntary accreditation of 
State, local, Tribal, and territorial health de-
533 
partments and public health laboratories for the 
purpose of advancing the quality and perform-
ance of such departments and laboratories; and 
(B) implement a program to accredit such 
health departments and laboratories in accord-
ance with such standards. 
(2) COOPERATIVE AGREEMENT.—The Secretary 
may enter into a cooperative agreement with a pri-
vate nonprofit entity to carry out paragraph (1). 
(h) REPORT.—The Secretary shall submit to the Con-
gress an annual report on progress being made to accredit 
entities under subsection (g), including— 
(1) a strategy, including goals and objectives, 
for accrediting entities under subsection (g) and 
achieving the purpose described in subsection 
(g)(1)(A); 
(2) identification of gaps in research related to 
core public health infrastructure; and 
(3) recommendations of priority areas for such 
research. 
(i) DEFINITION.—In this section, the term ‘‘core pub-
lic health infrastructure’’ includes— 
(1) workforce capacity and competency; 
(2) laboratory systems;
534 
(3) testing capacity, including test platforms, 
mobile testing units, and personnel; 
(4) health information, health information sys-
tems, and health information analysis; 
(5) disease surveillance; 
(6) contact tracing; 
(7) communications; 
(8) financing; 
(9) other relevant components of organizational 
capacity; and 
(10) other related activities. 
(j) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there are authorized to be appropriated 
$6,000,000,000, to remain available until expended. 
SEC. 30551. CORE PUBLIC HEALTH INFRASTRUCTURE AND 
ACTIVITIES FOR CDC. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall expand and improve the core public health in-
frastructure and activities of the Centers for Disease Con-
trol and Prevention to address unmet and emerging public 
health needs. 
(b) REPORT.—The Secretary shall submit to the Con-
gress an annual report on the activities funded through 
this section.
535 
(c) DEFINITION.—In this section, the term ‘‘core 
public health infrastructure’’ has the meaning given to 
such term in section 30550. 
(d) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$1,000,000,000, to remain available until expended. 
Subtitle 
D—COVID–19 
National 
Testing and Contact Tracing 
Initiative 
SEC. 30561. NATIONAL SYSTEM FOR COVID–19 TESTING, 
CONTACT TRACING, SURVEILLANCE, CON-
TAINMENT, AND MITIGATION. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, and in coordination with State, local, Tribal, and ter-
ritorial health departments, shall establish and implement 
a nationwide evidence-based system for— 
(1) testing, contact tracing, surveillance, con-
tainment, and mitigation with respect to COVID–19; 
(2) offering guidance on voluntary isolation and 
quarantine of individuals infected with, or exposed to 
individuals infected with, the virus that causes 
COVID–19; and
536 
(3) public reporting on testing, contact tracing, 
surveillance, and voluntary isolation and quarantine 
activities with respect to COVID–19. 
(b) COORDINATION; TECHNICAL ASSISTANCE.—In 
carrying out the national system under this section, the 
Secretary shall— 
(1) coordinate State, local, Tribal, and terri-
torial activities related to testing, contact tracing, 
surveillance, containment, and mitigation with re-
spect to COVID–19, as appropriate; and 
(2) provide technical assistance for such activi-
ties, as appropriate. 
(c) CONSIDERATION.—In establishing and imple-
menting the national system under this section, the Sec-
retary shall take into consideration— 
(1) the State plans referred to in the heading 
‘‘Public Health and Social Services Emergency 
Fund’’ in title I of division B of the Paycheck Pro-
tection Program and Health Care Enhancement Act 
(Public Law 116–139); and 
(2) the testing strategy submitted under section 
30541. 
(d) REPORTING.—The Secretary shall— 
(1) not later than December 31, 2020, submit 
to the Committee on Energy and Commerce of the
537 
House of Representatives and the Committee on 
Health, Education, Labor and Pensions a prelimi-
nary report on the effectiveness of the activities car-
ried out pursuant to this subtitle; and 
(2) not later than December 21, 2021, submit 
to such committees a final report on such effective-
ness. 
SEC. 30562. GRANTS. 
(a) IN GENERAL.—To implement the national system 
under section 30561, the Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall, subject to the availability of appropriations, 
award grants to State, local, Tribal, and territorial health 
departments that seek grants under this section to carry 
out coordinated testing, contact tracing, surveillance, con-
tainment, and mitigation with respect to COVID–19, in-
cluding— 
(1) diagnostic and surveillance testing and re-
porting; 
(2) community-based contact tracing efforts; 
and 
(3) policies related to voluntary isolation and 
quarantine of individuals infected with, or exposed to 
individuals infected with, the virus that causes 
COVID–19.
538 
(b) FLEXIBILITY.—The Secretary shall ensure that— 
(1) the grants under subsection (a) provide 
flexibility for State, local, Tribal, and territorial 
health departments to modify, establish, or maintain 
evidence-based systems; and 
(2) local health departments receive funding 
from State health departments or directly from the 
Centers for Disease Control and Prevention to con-
tribute to such systems, as appropriate. 
(c) ALLOCATIONS.— 
(1) FORMULA.—The Secretary, acting through 
the Director of the Centers for Disease Control and 
Prevention, shall allocate amounts made available 
pursuant to subsection (a) in accordance with a for-
mula to be established by the Secretary that pro-
vides a minimum level of funding to each State, 
local, Tribal, and territorial health department that 
seeks a grant under this section and allocates addi-
tional funding based on the following prioritization: 
(A) The Secretary shall give highest pri-
ority to applicants proposing to serve popu-
lations in one or more geographic regions with 
a high burden of COVID–19 based on data pro-
vided by the Centers for Disease Control and
539 
Prevention, or other sources as determined by 
the Secretary. 
(B) The Secretary shall give second high-
est priority to applicants preparing for, or cur-
rently working to mitigate, a COVID–19 surge 
in a geographic region that does not yet have 
a high number of reported cases of COVID–19 
based on data provided by the Centers for Dis-
ease Control and Prevention, or other sources 
as determined by the Secretary. 
(C) The Secretary shall give third highest 
priority to applicants proposing to serve high 
numbers of low-income and uninsured popu-
lations, including medically underserved popu-
lations (as defined in section 330(b)(3) of the 
Public 
Health 
Service 
Act 
(42 
U.S.C. 
254b(b)(3))), health professional shortage areas 
(as defined under section 332(a) of the Public 
Health Service Act (42 U.S.C. 254e(a))), racial 
and ethnic minorities, or geographically diverse 
areas, as determined by the Secretary. 
(2) NOTIFICATION.—Not later than the date 
that is one week before first awarding grants under 
this section, the Secretary shall submit to the Com-
mittee on Energy and Commerce of the House of
540 
Representatives and the Committee on Health, Edu-
cation, Labor and Pensions of the Senate a notifica-
tion detailing the formula established under para-
graph (1) for allocating amounts made available pur-
suant to subsection (a). 
(d) USE OF FUNDS.—A State, local, Tribal, and ter-
ritorial health department receiving a grant under this 
section shall, to the extent possible, use the grant funds 
for the following activities, or other activities deemed ap-
propriate by the Director of the Centers for Disease Con-
trol and Prevention: 
(1) TESTING.—To implement a coordinated 
testing system that— 
(A) leverages or modernizes existing test-
ing infrastructure and capacity; 
(B) is consistent with the updated testing 
strategy required under section 30541; 
(C) is coordinated with the State plan for 
COVID–19 testing prepared as required under 
the heading ‘‘Department of Health and 
Human Services—Office of the Secretary— 
Public Health and Social Service Emergency 
Fund’’ in title I of division B of the Paycheck 
Protection Program and Health Care Enhance-
541 
ment Act (Public Law 116–139; 134 Stat. 620, 
624); 
(D) is informed by contact tracing and 
surveillance activities under this subtitle; 
(E) is informed by guidelines established 
by the Centers for Disease Control and Preven-
tion for which populations should be tested; 
(F) identifies how diagnostic and sero-
logical tests in such system shall be validated 
prior to use; 
(G) identifies how diagnostic and sero-
logical tests and testing supplies will be distrib-
uted to implement such system; 
(H) identifies specific strategies for ensur-
ing testing capabilities and accessibility in 
medically underserved populations (as defined 
in section 330(b)(3) of the Public Health Serv-
ice Act (42 U.S.C. 254b(b)(3))), health profes-
sional shortage areas (as defined under section 
332(a) of the Public Health Service Act (42 
U.S.C. 254e(a))), racial and ethnic minority 
populations, and geographically diverse areas, 
as determined by the Secretary; 
(I) identifies how testing may be used, and 
results may be reported, in both health care set-
542 
tings (such as hospitals, laboratories for mod-
erate or high-complexity testing, pharmacies, 
mobile testing units, and community health cen-
ters) and non-health care settings (such as 
workplaces, schools, childcare centers, or drive- 
throughs); 
(J) allows for testing in sentinel surveil-
lance programs, as appropriate; and 
(K) supports the procurement and dis-
tribution of diagnostic and serological tests and 
testing supplies to meet the goals of the system. 
(2) CONTACT TRACING.—To implement a co-
ordinated contact tracing system that— 
(A) leverages or modernizes existing con-
tact tracing systems and capabilities, including 
community health workers, health departments, 
and Federally qualified health centers; 
(B) is able to investigate cases of COVID– 
19, and help to identify other potential cases of 
COVID–19, through tracing contacts of individ-
uals with positive diagnoses; 
(C) establishes culturally competent and 
multilingual strategies for contact tracing, 
which may include consultation with and sup-
543 
port for cultural or civic organizations with es-
tablished ties to the community; 
(D) provides individuals identified under 
the contact tracing program with information 
and support for containment or mitigation; 
(E) enables State, local, Tribal, and terri-
torial health departments to work with a non-
governmental, community partner or partners 
and State and local workforce development sys-
tems (as defined in section 3(67) of Workforce 
Innovation and Opportunity Act (29 U.S.C. 
3102(67))) receiving grants under section 
30566(b) of this Act to hire and compensate a 
locally-sourced contact tracing workforce, if 
necessary, to supplement the public health 
workforce, to— 
(i) identify the number of contact 
tracers needed for the respective State, lo-
cality, territorial, or Tribal health depart-
ment to identify all cases of COVID–19 
currently in the jurisdiction and those an-
ticipated to emerge over the next 18 
months in such jurisdiction; 
(ii) outline qualifications necessary for 
contact tracers;
544 
(iii) train the existing and newly hired 
public health workforce on best practices 
related to tracing close contacts of individ-
uals diagnosed with COVID–19, including 
the protection of individual privacy and cy-
bersecurity protection; and 
(iv) equip the public health workforce 
with tools and resources to enable a rapid 
response to new cases; 
(F) identifies the level of contact tracing 
needed within the State, locality, territory, or 
Tribal area to contain and mitigate the trans-
mission of COVID–19; 
(G) establishes statewide mechanisms to 
integrate regular evaluation to the Centers for 
Disease Control and Prevention regarding con-
tact tracing efforts, makes such evaluation pub-
licly available, and to the extent possible pro-
vides for such evaluation at the county level; 
and 
(H) identifies specific strategies for ensur-
ing contact tracing activities in medically un-
derserved populations (as defined in section 
330(b)(3) of the Public Health Service Act (42 
U.S.C. 254b(b)(3))), health professional short-
545 
age areas (as defined under section 332(a) of 
the Public Health Service Act (42 U.S.C. 
254e(a))), racial and ethnic minority popu-
lations, and geographically diverse areas, as de-
termined by the Secretary. 
(3) SURVEILLANCE.—To strengthen the exist-
ing public health surveillance system that— 
(A) leverages or modernizes existing sur-
veillance systems within the respective State, 
local, Tribal, or territorial health department 
and national surveillance systems; 
(B) detects and identifies trends in 
COVID–19 at the county level; 
(C) evaluates State, local, Tribal, and ter-
ritorial health departments in achieving surveil-
lance capabilities with respect to COVID–19; 
(D) integrates and improves disease sur-
veillance and immunization tracking; and 
(E) identifies specific strategies for ensur-
ing disease surveillance in medically under-
served populations (as defined in section 
330(b)(3) of the Public Health Service Act (42 
U.S.C. 254b(b)(3))), health professional short-
age areas (as defined under section 332(a) of 
the Public Health Service Act (42 U.S.C.
546 
254e(a))), racial and ethnic minority popu-
lations, and geographically diverse areas, as de-
termined by the Secretary. 
(4) CONTAINMENT AND MITIGATION.—To im-
plement a coordinated containment and mitigation 
system that— 
(A) leverages or modernizes existing con-
tainment and mitigation strategies within the 
respective State, local, Tribal, or territorial gov-
ernments and national containment and mitiga-
tion strategies; 
(B) may provide for, connect to, and lever-
age existing social services and support for indi-
viduals who have been infected with or exposed 
to COVID–19 and who are isolated or quar-
antined in their homes, such as through— 
(i) food assistance programs; 
(ii) guidance for household infection 
control; 
(iii) information and assistance with 
childcare services; and 
(iv) information and assistance per-
taining to support available under the 
CARES Act (Public Law 116–136) and 
this Act;
547 
(C) provides guidance on the establishment 
of safe, high-quality, facilities for the voluntary 
isolation of individuals infected with, or quar-
antine of the contacts of individuals exposed to 
COVID–19, where hospitalization is not re-
quired, which facilities should— 
(i) be prohibited from making inquir-
ies relating to the citizenship status of an 
individual isolated or quarantined; and 
(ii) be operated by a non-Federal, 
community partner or partners that— 
(I) have previously established re-
lationships in localities; 
(II) work with local places of 
worship, community centers, medical 
facilities, and schools to recruit local 
staff for such facilities; and 
(III) are fully integrated into 
State, local, Tribal, or territorial con-
tainment and mitigation efforts; and 
(D) identifies specific strategies for ensur-
ing containment and mitigation activities in 
medically underserved populations (as defined 
in section 330(b)(3) of the Public Health Serv-
ice Act (42 U.S.C. 254b(b)(3))), health profes-
548 
sional shortage areas (as defined under section 
332(a) of the Public Health Service Act (42 
U.S.C. 254e(a))), racial and ethnic minority 
populations, and geographically diverse areas, 
as determined by the Secretary. 
(e) REPORTING.—The Secretary shall facilitate 
mechanisms for timely, standardized reporting by grantees 
under this section regarding implementation of the sys-
tems established under this section and coordinated proc-
esses with the reporting as required and under the heading 
‘‘Department of Health and Human Services—Office of 
the Secretary—Public Health and Social Service Emer-
gency Fund’’ in title I of division B of the Paycheck Pro-
tection Program and Health Care Enhancement Act (Pub-
lic Law 116–139, 134 Stat. 620), including— 
(1) a summary of county or local health depart-
ment level information from the States receiving 
funding, and information from directly funded local-
ities, territories, and Tribal entities, about the activi-
ties that will be undertaken using funding awarded 
under this section, including subgrants; 
(2) any anticipated shortages of required mate-
rials for testing for COVID–19 under subsection (a); 
and
549 
(3) other barriers in the prevention, mitigation, 
or treatment of COVID–19 under this section. 
(f) PUBLIC LISTING OF AWARDS.—The Secretary 
shall— 
(1) not later than 7 days after first awarding 
grants under this section, post in a searchable, elec-
tronic format a list of all awards made by the Sec-
retary under this section, including the recipients 
and amounts of such awards; and 
(2) update such list not less than every 7 days 
until all funds made available to carry out this sec-
tion are expended. 
SEC. 30563. GUIDANCE, TECHNICAL ASSISTANCE, INFORMA-
TION, AND COMMUNICATION. 
(a) IN GENERAL.— Not later than 14 days after the 
date of the enactment of this Act, the Secretary, in coordi-
nation with other Federal agencies, as appropriate, shall 
issue guidance, provide technical assistance, and provide 
information to States, localities, Tribes, and territories, 
with respect to the following: 
(1) The diagnostic and serological testing of in-
dividuals identified through contact tracing for 
COVID–19, including information with respect to 
the reduction of duplication related to programmatic 
activities, reporting, and billing.
550 
(2) Best practices regarding contact tracing, in-
cluding the collection of data with respect to such 
contact tracing and requirements related to the 
standardization of demographic and syndromic infor-
mation collected as part of contact tracing efforts. 
(3) Best practices regarding COVID–19 disease 
surveillance, including best practices to reduce dupli-
cation in surveillance activities, identifying gaps in 
surveillance and surveillance systems, and ways in 
which the Secretary plans to effectively support 
State, local, Tribal and territorial health depart-
ments in addressing such gaps. 
(4) Information on ways for State, local, Tribal, 
and territorial health departments to establish and 
maintain the testing, contact tracing, and surveil-
lance activities described in paragraphs (1) through 
(3). 
(5) The protection of any personally identifiable 
health information collected pursuant to this sub-
title. 
(6) Best practices regarding privacy and cyber-
security protection related to contact tracing, con-
tainment, and mitigation efforts. 
(b) GUIDANCE ON PAYMENT.—Not later than 14 
days after the date of the enactment of this Act, the Sec-
551 
retary, in coordination with the Administrator of the Cen-
ters for Medicare & Medicaid Services, the Director of the 
Centers for Disease Control and Prevention, and in coordi-
nation with other Federal agencies, as appropriate, shall 
develop and issue to State, local, Tribal, and territorial 
health departments clear guidance and policies— 
(1) with respect to the coordination of claims 
submitted for payment out of the Public Health and 
Social Services Emergency Fund for services fur-
nished 
in 
a 
facility 
referred 
to 
in 
section 
30562(d)(4)(C); 
(2) identifying how an individual who is isolated 
or quarantined at home or in such a facility— 
(A) incurs no out-of-pocket costs for any 
services furnished to such individual while iso-
lated; and 
(B) may receive income support for lost 
earnings or payments for expenses such as child 
care or elder care while such individual is iso-
lated at home or in such a facility; 
(3) providing information and assistance per-
taining to support available under the CARES Act 
(Public Law 116–136) and this Act; and 
(4) identifying State, local, Tribal, and terri-
torial health departments or partner agencies that
552 
may provide social support services, such as gro-
ceries or meals, health education, internet access, 
and behavioral health services, to individuals who 
isolated or quarantined at home or in such a facility. 
(c) GUIDANCE ON TESTING.—Not later than 14 days 
after the date of the enactment of this Act, the Secretary, 
in coordination with the Commissioner of Food and 
Drugs, the Director of the National Institutes of Health, 
and the Director of the Centers for Disease Control and 
Prevention, and in coordination with other Federal agen-
cies as appropriate, shall develop and issue to State, local, 
Tribal, and territorial health departments clear guidance 
and policies regarding— 
(1) objective standards to characterize the per-
formance of all diagnostic and serological tests for 
COVID–19 in order to independently evaluate tests 
continuously over time; 
(2) protocols for the evaluation of the perform-
ance of diagnostic and serological tests for COVID– 
19; and 
(3) a repository of characterized specimens to 
use to evaluate the performance of those tests that 
can be made available for appropriate entities to use 
to evaluate performance.
553 
(d) COMMUNICATION.—The Secretary shall identify 
and publicly announce the form and manner for commu-
nication with State, local, Tribal, and territorial health de-
partments for purposes of carrying out the activities ad-
dressed by guidance issued under subsections (a) and (b). 
(e) AVAILABILITY TO PROVIDERS.—Guidance issued 
under subsection (a)(1) shall be issued to health care pro-
viders. 
(f) ONGOING PROVISION OF GUIDANCE AND TECH-
NICAL ASSISTANCE.—Notwithstanding whether funds are 
available specifically to carry out this subtitle, guidance 
and technical assistance shall continue to be provided 
under this section. 
SEC. 30564. RESEARCH AND DEVELOPMENT. 
The Secretary, in coordination with the Director of 
the Centers for Disease Control and Prevention and in col-
laboration with the Director of the National Institutes of 
Health, the Director of the Agency for Healthcare Re-
search and Quality, the Commissioner of Food and Drugs, 
and the Administrator of the Centers for Medicare & Med-
icaid Services, shall support research and development on 
more efficient and effective strategies— 
(1) for the surveillance of SARS–CoV–2 and 
COVID–19;
554 
(2) for the testing and identification of individ-
uals infected with COVID–19; and 
(3) for the tracing of contacts of individuals in-
fected with COVID–19. 
SEC. 30565. AWARENESS CAMPAIGNS. 
The Secretary, acting through the Director of the 
Centers for Disease Control and Prevention and in coordi-
nation with other offices and agencies, as appropriate, 
shall award competitive grants or contracts to one or more 
public or private entities, including faith-based organiza-
tions, to carry out multilingual and culturally appropriate 
awareness campaigns. Such campaigns shall— 
(1) be based on available scientific evidence; 
(2) increase awareness and knowledge of 
COVID–19, including countering stigma associated 
with COVID–19; 
(3) improve information on the availability of 
COVID–19 diagnostic testing; and 
(4) promote cooperation with contact tracing ef-
forts. 
SEC. 30566. GRANTS TO STATE AND TRIBAL WORKFORCE 
AGENCIES. 
(a) DEFINITIONS.—In this section: 
(1) IN
GENERAL.—Except as otherwise pro-
vided, the terms in this section have the meanings
555 
given the terms in section 3 of the Workforce Inno-
vation and Opportunity Act (29 U.S.C. 3102). 
(2) APPRENTICESHIP; APPRENTICESHIP
PRO-
GRAM.—The term ‘‘apprenticeship’’ or ‘‘apprentice-
ship program’’ means an apprenticeship program 
registered under the Act of August 16, 1937 (com-
monly known as the ‘‘National Apprenticeship Act’’) 
(50 Stat. 664, chapter 663; 29 U.S.C. 50 et seq.), 
including any requirement, standard, or rule promul-
gated under such Act, as such requirement, stand-
ard, or rule was in effect on December 30, 2019. 
(3) CONTACT
TRACING
AND
RELATED
POSI-
TIONS.—The term ‘‘contact tracing and related posi-
tions’’ means employment related to contact tracing, 
surveillance, containment, and mitigation activities 
as described in paragraphs (2), (3), and (4) of sec-
tion 30562(d). 
(4) ELIGIBLE ENTITY.—The term ‘‘eligible enti-
ty’’ means— 
(A) a State or territory, including the Dis-
trict of Columbia and Puerto Rico; 
(B) an Indian Tribe, Tribal organization, 
Alaska Native entity, Indian-controlled organi-
zations serving Indians, or Native Hawaiian or-
ganizations;
556 
(C) an outlying area; or 
(D) a local board, if an eligible entity 
under subparagraphs (A) through (C) has not 
applied with respect to the area over which the 
local board has jurisdiction as of the date on 
which the local board submits an application 
under subsection (c). 
(5) ELIGIBLE
INDIVIDUAL.—Notwithstanding 
section 170(b)(2) of the Workforce Innovation and 
Opportunity Act (29 U.S.C. 3225(b)(2)), the term 
‘‘eligible individual’’ means an individual seeking or 
securing employment in contact tracing and related 
positions and served by an eligible entity or commu-
nity-based organization receiving funding under this 
section. 
(6) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of Labor. 
(b) GRANTS.— 
(1) IN GENERAL.—Subject to the availability of 
appropriations under subsection (g), the Secretary 
shall award national dislocated worker grants under 
section 170(b)(1)(B) of the Workforce Innovation 
and Opportunity Act (29 U.S.C. 3225(b)(1)(B)) to 
each eligible entity that seeks a grant to assist local 
boards and community-based organizations in car-
557 
rying out activities under subsections (f) and (d), re-
spectively, for the following purposes: 
(A) To support the recruitment, place-
ment, and training, as applicable, of eligible in-
dividuals seeking employment in contact tracing 
and related positions in accordance with the na-
tional system for COVID–19 testing, contact 
tracing, surveillance, containment, and mitiga-
tion established under section 30561. 
(B) To assist with the employment transi-
tion to new employment or education and train-
ing of individuals employed under this section 
in preparation for and upon termination of such 
employment. 
(2) TIMELINE.—The Secretary of Labor shall— 
(A) issue application requirements under 
subsection (c) not later than 10 days after the 
date of enactment of this section; and 
(B) award grants to an eligible entity 
under paragraph (1) not later than 10 days 
after the date on which the Secretary receives 
an application from such entity. 
(c) GRANT APPLICATION.—An eligible entity apply-
ing for a grant under this section shall submit an applica-
tion to the Secretary, at such time and in such form and
558 
manner as the Secretary may reasonably require, which 
shall include a description of— 
(1) how the eligible entity will support the re-
cruitment, placement, and training, as applicable, of 
eligible individuals seeking employment in contact 
tracing and related positions by partnering with— 
(A) a State, local, Tribal, or territorial 
health department; or 
(B) one or more nonprofit or community- 
based organizations partnering with such health 
departments; 
(2) how the activities described in paragraph 
(1) will support State efforts to address the demand 
for contact tracing and related positions with respect 
to— 
(A) the State plans referred to in the head-
ing ‘‘Public Health and Social Services Emer-
gency Fund’’ in title I of division B of the Pay-
check Protection Program and Health Care En-
hancement Act (Public Law 116–139); 
(B) the testing strategy submitted under 
section 30541; and 
(C) the number of eligible individuals that 
the State plans to recruit and train under the
559 
plans and strategies described in subparagraphs 
(A) and (B); 
(3) the specific strategies for recruiting and 
placement of eligible individuals from or residing 
within the communities in which they will work, in-
cluding— 
(A) plans for the recruitment of eligible in-
dividuals to serve as contact tracers and related 
positions, including dislocated workers, individ-
uals with barriers to employment, veterans, new 
entrants in the workforce, or underemployed or 
furloughed workers, who are from or reside in 
or near the local area in which they will serve, 
and who, to the extent practicable— 
(i) have experience or a background in 
industry-sectors and occupations such as 
public health, social services, customer 
service, case management, or occupations 
that require related qualifications, skills, or 
competencies, such as strong interpersonal 
and communication skills, needed for con-
tact tracing and related positions, as de-
scribed in section 30562(d)(2)(E)(ii); or 
(ii) seek to transition to public health 
and public health related occupations upon
560 
the conclusion of employment in contact 
tracing and related positions; and 
(B) how such strategies will take into ac-
count the diversity of such community, includ-
ing racial, ethnic, socioeconomic, linguistic, or 
geographic diversity; 
(4) the amount, timing, and mechanisms for 
distribution of funds provided to local boards or 
through subgrants as described in subsection (d); 
(5) for eligible entities described in subpara-
graphs (A) through (C) of subsection (a)(4), a de-
scription of how the eligible entity will ensure the eq-
uitable distribution of funds with respect to— 
(A) geography (such as urban and rural 
distribution); 
(B) medically underserved populations (as 
defined in section 33(b)(3) of the Public Health 
Service Act (42 U.S.C. 254b(b))); 
(C) health professional shortage areas (as 
defined under section 332(a) of the Public 
Health Service Act (42 U.S.C. 254e(a))); and 
(D) the racial and ethnic diversity of the 
area; and 
(6) for eligible entities who are local boards, a 
description of how a grant to such eligible entity
561 
would serve the equitable distribution of funds as de-
scribed in paragraph (5). 
(d) SUBGRANT AUTHORIZATION AND APPLICATION 
PROCESS.— 
(1) IN GENERAL.—An eligible entity may award 
a subgrant to one or more community-based organi-
zations for the purposes of partnering with a State 
or local board to conduct outreach and education ac-
tivities to inform potentially eligible individuals 
about employment opportunities in contact tracing 
and related positions. 
(2) APPLICATION.—A community-based organi-
zation shall submit an application at such time and 
in such manner as the eligible entity may reasonably 
require, including— 
(A) a demonstration of the community- 
based organization’s established expertise and 
effectiveness in community outreach in the local 
area that such organization plans to serve; 
(B) a demonstration of the community- 
based organization’s expertise in providing em-
ployment or public health information to the 
local areas in which such organization plans to 
serve; and
562 
(C) a description of the expertise of the 
community-based organization in utilizing cul-
turally competent and multilingual strategies in 
the provision of services. 
(e) GRANT DISTRIBUTION.— 
(1) FEDERAL DISTRIBUTION.— 
(A) USE OF FUNDS.— The Secretary of 
Labor shall use the funds appropriated to carry 
out this section as follows: 
(i) Subject to clause (ii), the Secretary 
shall distribute funds among eligible enti-
ties in accordance with a formula to be es-
tablished by the Secretary that provides a 
minimum level of funding to each eligible 
entity that seeks a grant under this section 
and allocates additional funding as follows: 
(I) The formula shall give first 
priority based on the number and pro-
portion of contact tracing and related 
positions that the State plans to re-
cruit, place, and train individuals as a 
part of the State strategy described in 
subsection (c)(2)(A).
563 
(II) Subject to subclause (I), the 
formula shall give priority in accord-
ance with section 30562(c). 
(ii) Not more than 2 percent of the 
funding for administration of the grants 
and for providing technical assistance to 
recipients of funds under this section. 
(B) EQUITABLE DISTRIBUTION.—If the ge-
ographic region served by one or more eligible 
entities overlaps, the Secretary shall distribute 
funds among such entities in such a manner 
that ensures equitable distribution with respect 
to the factors under subsection (c)(5). 
(2) ELIGIBLE ENTITY USE OF FUNDS.—An eli-
gible entity described in subparagraphs (A) through 
(C) of subsection (a)(4)— 
(A) shall, not later than 30 days after the 
date on which the entity receives grant funds 
under this section, provide not less than 70 per-
cent of grant funds to local boards for the pur-
pose of carrying out activities in subsection (f); 
(B) may use up to 20 percent of such 
funds to make subgrants to community-based 
organizations in the service area to conduct out-
564 
reach, to potential eligible individuals, as de-
scribed in subsection (d); 
(C) in providing funds to local boards and 
awarding subgrants under this subsection shall 
ensure the equitable distribution with respect to 
the factors described in subsection (c)(5); and 
(D) may use not more than 10 percent of 
the funds awarded under this section for the 
administrative costs of carrying out the grant 
and for providing technical assistance to local 
boards and community-based organizations. 
(3) LOCAL
BOARD
USE
OF
FUNDS.—A local 
board, or an eligible entity that is a local board, 
shall use— 
(A) not less than 60 percent of the funds 
for recruitment and training for COVID–19 
testing, contact tracing, surveillance, contain-
ment, and mitigation established under section 
30561; 
(B) not less than 30 of the funds to sup-
port the transition of individuals hired as con-
tact tracers and related positions into an edu-
cation or training program, or unsubsidized em-
ployment upon completion of such positions; 
and
565 
(C) not more than 10 percent of the funds 
for administrative costs. 
(f) ELIGIBLE ACTIVITIES.—The State or local boards 
shall use funds awarded under this section to support the 
recruitment and placement of eligible individuals, training 
and employment transition as related to contact tracing 
and related positions, and for the following activities: 
(1) Establishing or expanding partnerships 
with— 
(A) State, local, Tribal, and territorial 
public health departments; 
(B) community-based health providers, in-
cluding community health centers and rural 
health clinics; 
(C) labor organizations or joint labor man-
agement organizations; 
(D) two-year and four-year institutions of 
higher education (as defined in section 101 of 
the Higher Education Act of 1965 (20 U.S.C. 
1001)), including institutions eligible to receive 
funds under section 371(a) of the Higher Edu-
cation Act of 1965 (20 U.S.C. 1067q(a)); and 
(E) community action agencies or other 
community-based organizations serving local
566 
areas in which there is a demand for contact 
tracing and related positions. 
(2) Providing training for contact tracing and 
related positions in coordination with State, local, 
Tribal, or territorial health departments that is con-
sistent with the State or territorial testing and con-
tact tracing strategy, and ensuring that eligible indi-
viduals receive compensation while participating in 
such training. 
(3) Providing eligible individuals with— 
(A) adequate and safe equipment, environ-
ments, and facilities for training and super-
vision, as applicable; 
(B) information regarding the wages and 
benefits related to contact tracing and related 
positions, as compared to State, local, and na-
tional averages; 
(C) supplies and equipment needed by the 
eligible individuals to support placement of an 
individual in contact tracing and related posi-
tions, as applicable; 
(D) an individualized employment plan for 
each eligible individual, as applicable—
567 
(i) in coordination with the entity em-
ploying the eligible individual in a contact 
tracing and related positions; and 
(ii) which shall include providing a 
case manager to work with each eligible in-
dividual to develop the plan, which may in-
clude— 
(I) identifying employment and 
career goals, and setting appropriate 
achievement objectives to attain such 
goals; and 
(II) exploring career pathways 
that lead to in-demand industries and 
sectors, including in public health and 
related occupations; and 
(E) services for the period during which 
the eligible individual is employed in a contact 
tracing and related position to ensure job reten-
tion, which may include— 
(i) supportive services throughout the 
term of employment; 
(ii) a continuation of skills training as 
related to employment in contact tracing 
and related positions, that is conducted in
568 
collaboration with the employers of such 
individuals; 
(iii) mentorship services and job re-
tention support for eligible individuals; or 
(iv) targeted training for managers 
and workers working with eligible individ-
uals (such as mentors), and human re-
source representatives; 
(4) Supporting the transition and placement in 
unsubsidized employment for eligible individuals 
serving in contact tracing and related positions after 
such positions are no longer necessary in the State 
or local area, including— 
(A) any additional training and employ-
ment activities as described in section 170(d)(4) 
of the Workforce Innovation and Opportunity 
Act (29 U.S.C. 3225(d)(4)); 
(B) developing the appropriate combina-
tion of services to enable the eligible individual 
to achieve the employment and career goals 
identified under paragraph (3)(D)(ii)(I); and 
(C) services to assist eligible individuals in 
maintaining employment for not less than 12 
months after the completion of employment in
569 
contact tracing and related positions, as appro-
priate. 
(5) Any other activities as described in sub-
sections (a)(3) and (b) of section 134 of the Work-
force Innovation and Opportunity Act (29 U.S.C. 
3174). 
(g) 
LIMITATION.—Notwithstanding 
section 
170(d)(3)(A) of the Workforce Innovation and Oppor-
tunity Act (29 U.S.C. 3225(d)(3)(A)), a person may be 
employed in a contact tracing and related positions using 
funds under this section for a period not greater than 2 
years. 
(h) REPORTING BY THE DEPARTMENT OF LABOR.— 
(1) IN GENERAL.—Not later than 120 days of 
the enactment of this Act, and once grant funds 
have been expended under this section, the Secretary 
shall report to the Committee on Education and 
Labor of the House of Representatives and the Com-
mittee on Health, Education, Labor and Pensions of 
the Senate, and make publicly available a report 
containing a description of— 
(A) the number of eligible individuals re-
cruited, hired, and trained in contact tracing 
and related positions;
570 
(B) the number of individuals successfully 
transitioned to unsubsidized employment or 
training at the completion of employment in 
contact tracing and related positions using 
funds under this subtitle; 
(C) the number of such individuals who 
were unemployed prior to being hired, trained, 
or deployed as described in paragraph (1); 
(D) the performance of each program sup-
ported by funds under this subtitle with respect 
to the indicators of performance under section 
116 of the Workforce Innovation and Oppor-
tunity Act (29 U.S.C. 3141), as applicable; 
(E) the number of individuals in unsub-
sidized employment within six months and 1 
year, respectively, of the conclusion of employ-
ment in contact tracing and related positions 
and, of those, the number of individuals within 
a State, territorial, or local public health de-
partment in an occupation related to public 
health; 
(F) any information on how eligible enti-
ties, local boards, or community-based organiza-
tions that received funding under this sub-
section were able to support the goals of the na-
571 
tional system for COVID–19 testing, contact 
tracing, surveillance, containment, and mitiga-
tion established under section 30561 of this 
Act; and 
(G) best practices for improving and in-
creasing the transition of individuals employed 
in contract tracing and related positions to un-
subsidized employment. 
(2) DISAGGREGATION.—All data reported under 
paragraph (1) shall be disaggregated by race, eth-
nicity, sex, age, and, with respect to individuals with 
barriers to employment, subpopulation of such indi-
viduals, except for when the number of participants 
in a category is insufficient to yield statistically reli-
able information or when the results would reveal 
personally identifiable information about an indi-
vidual participant. 
(i) SPECIAL RULE.—Any funds used for programs 
under this section that are used to fund an apprenticeship 
or apprenticeship program shall only be used for, or pro-
vided to, an apprenticeship or apprenticeship program 
that meets the definition of such term subsection (a) of 
this section, including any funds awarded for the purposes 
of grants, contracts, or cooperative agreements, or the de-
572 
velopment, implementation, or administration, of an ap-
prenticeship or an apprenticeship program. 
(j) INFORMATION
SHARING
REQUIREMENT
FOR 
HHS.—The Secretary of Health and Human Services, 
acting through the Director of the Centers for Disease 
Control and Prevention, shall provide the Secretary of 
Labor, acting through the Assistant Secretary of the Em-
ployment and Training Administration, with information 
on grants under section 30562, including— 
(1) the formula used to award such grants to 
State, local, Tribal, and territorial health depart-
ments; 
(2) the dollar amounts of and scope of the work 
funded under such grants; 
(3) the geographic areas served by eligible enti-
ties that receive such grants; and 
(4) the number of contact tracers and related 
positions to be hired using such grants. 
(k) AUTHORIZATION OF APPROPRIATIONS.—Of the 
amounts appropriated to carry out this subtitle, 
$500,000,000 shall be used by the Secretary of Labor to 
carry out subsections (a) through (h) of this section.
573 
SEC. 30567. APPLICATION OF THE SERVICE CONTRACT ACT 
TO CONTRACTS AND GRANTS. 
Contracts and grants which include contact tracing 
as part of the scope of work and that are awarded under 
this subtitle shall require that contract tracers and related 
positions are paid not less than the prevailing wage and 
fringe rates required under chapter 67 of title 41, United 
States Code (commonly known as the ‘‘Service Contract 
Act’’) for the area in which the work is performed. To 
the extent that a nonstandard wage determination is re-
quired to establish a prevailing wage for contact tracers 
and related positions for purposes of this subtitle, the Sec-
retary of Labor shall issue such determination not later 
than 14 days after the date of enactment of this Act, 
based on a job description used by the Centers for Disease 
Control and Prevention and contractors or grantees per-
forming contact tracing for State public health agencies. 
SEC. 30568. AUTHORIZATION OF APPROPRIATIONS. 
To carry out this subtitle, there are authorized to be 
appropriated $75,000,000,000, to remain available until 
expended.
574 
Subtitle E—Demographic Data and 
Supply Reporting Related to 
COVID–19 
SEC. 30571. COVID–19 REPORTING PORTAL. 
(a) IN GENERAL.—Not later than 15 days after the 
date of enactment of this Act, the Secretary shall establish 
and maintain an online portal for use by eligible health 
care entities to track and transmit data regarding their 
personal protective equipment and medical supply inven-
tory and capacity related to COVID–19. 
(b) ELIGIBLE HEALTH CARE ENTITIES.—In this sec-
tion, the term ‘‘eligible health care entity’’ means a li-
censed acute care hospital, hospital system, or long-term 
care facility with confirmed cases of COVID–19. 
(c) SUBMISSION.—An eligible health care entity shall 
report using the portal under this section on a biweekly 
basis in order to assist the Secretary in tracking usage 
and need of COVID–related supplies and personnel in a 
regular and real-time manner. 
(d) INCLUDED INFORMATION.—The Secretary shall 
design the portal under this section to include information 
on personal protective equipment and medical supply in-
ventory and capacity related to COVID–19, including with 
respect to the following:
575 
(1) PERSONAL
PROTECTIVE
EQUIPMENT.— 
Total personal protective equipment inventory, in-
cluding, in units, the numbers of N95 masks and 
authorized equivalent respirator masks, surgical 
masks, exam gloves, face shields, isolation gowns, 
and coveralls. 
(2) MEDICAL SUPPLY.— 
(A) Total ventilator inventory, including, in 
units, the number of universal, adult, pediatric, 
and infant ventilators. 
(B) Total diagnostic and serological test 
inventory, including, in units, the number of 
test platforms, tests, test kits, reagents, trans-
port media, swabs, and other materials or sup-
plies determined necessary by the Secretary. 
(3) CAPACITY.— 
(A) Case count measurements, including 
confirmed positive cases and persons under in-
vestigation. 
(B) Total number of staffed beds, includ-
ing medical surgical beds, intensive care beds, 
and critical care beds. 
(C) Available beds, including medical sur-
gical beds, intensive care beds, and critical care 
beds.
576 
(D) Total number of COVID–19 patients 
currently utilizing a ventilator. 
(E) Average number of days a COVID–19 
patient is utilizing a ventilator. 
(F) Total number of additionally needed 
professionals in each of the following categories: 
intensivists, critical care physicians, respiratory 
therapists, registered nurses, certified registered 
nurse anesthetists, and laboratory personnel. 
(G) Total number of hospital personnel 
currently not working due to self-isolation fol-
lowing a known or presumed COVID–19 expo-
sure. 
(e) ACCESS TO INFORMATION RELATED TO INVEN-
TORY AND CAPACITY.—The Secretary shall ensure that 
relevant agencies and officials, including the Centers for 
Disease Control and Prevention, the Assistant Secretary 
for Preparedness and Response, and the Federal Emer-
gency Management Agency, have access to information re-
lated to inventory and capacity submitted under this sec-
tion. 
(f) WEEKLY REPORT TO CONGRESS.—On a weekly 
basis, the Secretary shall transmit information related to 
inventory and capacity submitted under this section to the 
appropriate committees of the House and Senate.
577 
SEC. 30572. REGULAR CDC REPORTING ON DEMOGRAPHIC 
DATA. 
Not later than 14 days after the date of enactment 
of this Act, the Secretary, in coordination with the Direc-
tor of the Centers for Disease Control and Prevention, 
shall amend the reporting under the heading ‘‘Department 
of Health and Human Services—Office of the Secretary— 
Public Health and Social Service Emergency Fund’’ in 
title I of division B of the Paycheck Protection Program 
and Health Care Enhancement Act (Public Law 116–139; 
134 Stat. 620, 626) on the demographic characteristics, 
including race, ethnicity, age, sex, gender, geographic re-
gion, and other relevant factors of individuals tested for 
or diagnosed with COVID–19, to include— 
(1) providing technical assistance to State, 
local, and territorial health departments to improve 
the collection and reporting of such demographic 
data; 
(2) if such data is not so collected or reported, 
the reason why the State, local, or territorial depart-
ment of health has not been able to collect or pro-
vide such information; and 
(3) making a copy of such report available pub-
licly on the website of the Centers for Disease Con-
trol and Prevention.
578 
SEC. 30573. FEDERAL MODERNIZATION FOR HEALTH IN-
EQUITIES DATA. 
(a) IN GENERAL.—The Secretary shall work with 
covered agencies to support the modernization of data col-
lection methods and infrastructure at such agencies for 
the purpose of increasing data collection related to health 
inequities, such as racial, ethnic, socioeconomic, sex, gen-
der, and disability disparities. 
(b) COVERED AGENCY DEFINED.—In this section, 
the term ‘‘covered agency’’ means each of the following 
Federal agencies: 
(1) The Agency for Healthcare Research and 
Quality. 
(2) The Centers for Disease Control and Pre-
vention. 
(3) The Centers for Medicare & Medicaid Serv-
ices. 
(4) The Food and Drug Administration. 
(5) The Office of the National Coordinator for 
Health Information Technology. 
(6) The National Institutes of Health. 
(c) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to each covered agency to 
carry out this section $4,000,000, to remain available 
until expended.
579 
SEC. 
30574. 
MODERNIZATION 
OF 
STATE 
AND 
LOCAL 
HEALTH INEQUITIES DATA. 
(a) IN GENERAL.—Not later than 6 months after the 
date of enactment of this Act, the Secretary, acting 
through the Director of the Centers for Disease Control 
and Prevention, shall award grants to State, local, and 
territorial health departments in order to support the 
modernization of data collection methods and infrastruc-
ture for the purposes of increasing data related to health 
inequities, such as racial, ethnic, socioeconomic, sex, gen-
der, and disability disparities. The Secretary shall— 
(1) provide guidance, technical assistance, and 
information to grantees under this section on best 
practices regarding culturally competent, accurate, 
and increased data collection and transmission; and 
(2) track performance of grantees under this 
section to help improve their health inequities data 
collection by identifying gaps and taking effective 
steps to support States, localities, and territories in 
addressing the gaps. 
(b) REPORT.—Not later than 1 year after the date 
on which the first grant is awarded under this section, 
the Secretary shall submit to the Committee on Energy 
and Commerce of the House of Representatives and the 
Committee on Health, Education, Labor and Pensions of 
the Senate an initial report detailing—
580 
(1) nationwide best practices for ensuring 
States and localities collect and transmit health in-
equities data; 
(2) nationwide trends which hinder the collec-
tion and transmission of health inequities data; 
(3) Federal best practices for working with 
States and localities to ensure culturally competent, 
accurate, and increased data collection and trans-
mission; and 
(4) any recommended changes to legislative or 
regulatory authority to help improve and increase 
health inequities data collection. 
(c) FINAL REPORT.—Not later than December 31, 
2023, the Secretary shall— 
(1) update and finalize the initial report under 
subsection (b); and 
(2) submit such final report to the committees 
specified in such subsection. 
(d) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$100,000,000, to remain available until expended. 
SEC. 30575. TRIBAL FUNDING TO RESEARCH HEALTH IN-
EQUITIES INCLUDING COVID–19. 
(a) IN GENERAL.—Not later than 6 months after the 
date of enactment of this Act, the Director of the Indian
581 
Health Service, in coordination with Tribal Epidemiology 
Centers and other Federal agencies, as appropriate, shall 
conduct or support research and field studies for the pur-
poses of improved understanding of Tribal health inequi-
ties among American Indians and Alaska Natives, includ-
ing with respect to— 
(1) disparities related to COVID–19; 
(2) public health surveillance and infrastructure 
regarding unmet needs in Indian country and Urban 
Indian communities; 
(3) population-based health disparities; 
(4) barriers to health care services; 
(5) the impact of socioeconomic status; and 
(6) factors contributing to Tribal health inequi-
ties. 
(b) CONSULTATION, CONFER, AND COORDINATION.— 
In carrying out this section, the Director of the Indian 
Health Service shall— 
(1) consult with Indian Tribes and Tribal orga-
nizations; 
(2) confer with Urban Indian organizations; 
and 
(3) coordinate with the Director of the Centers 
for Disease Control and Prevention and the Director 
of the National Institutes of Health.
582 
(c) PROCESS.—Not later than 60 days after the date 
of enactment of this Act, the Director of the Indian Health 
Service shall establish a nationally representative panel to 
establish processes and procedures for the research and 
field studies conducted or supported under subsection (a). 
The Director shall ensure that, at a minimum, the panel 
consists of the following individuals: 
(1) Elected Tribal leaders or their designees. 
(2) Tribal public health practitioners and ex-
perts from the national and regional levels. 
(d) DUTIES.—The panel established under subsection 
(c) shall, at a minimum— 
(1) advise the Director of the Indian Health 
Service on the processes and procedures regarding 
the design, implementation, and evaluation of, and 
reporting on, research and field studies conducted or 
supported under this section; 
(2) develop and share resources on Tribal pub-
lic health data surveillance and reporting, including 
best practices; and 
(3) carry out such other activities as may be 
appropriate to establish processes and procedures for 
the research and field studies conducted or sup-
ported under subsection (a).
583 
(e) REPORT.—Not later than 1 year after expending 
all funds made available to carry out this section, the Di-
rector of the Indian Health Service, in coordination with 
the panel established under subsection (c), shall submit 
an initial report on the results of the research and field 
studies under this section to— 
(1) the Committee on Energy and Commerce 
and the Committee on Natural Resources of the 
House of Representatives; and 
(2) the Committee on Indian Affairs and the 
Committee on Health, Education, Labor and Pen-
sions of the Senate. 
(f) TRIBAL DATA SOVEREIGNTY.—The Director of 
the Indian Health Service shall ensure that all research 
and field studies conducted or supported under this sec-
tion are tribally-directed and carried out in a manner 
which ensures Tribal-direction of all data collected under 
this section— 
(1) according to Tribal best practices regarding 
research design and implementation, including by 
ensuring the consent of the Tribes involved to public 
reporting of Tribal data; 
(2) according to all relevant and applicable 
Tribal, professional, institutional, and Federal
584 
standards for conducting research and governing re-
search ethics; 
(3) with the prior and informed consent of any 
Indian Tribe participating in the research or sharing 
data for use under this section; and 
(4) in a manner that respects the inherent sov-
ereignty of Indian Tribes, including Tribal govern-
ance of data and research. 
(g) FINAL REPORT.—Not later than December 31, 
2023, the Director of the Indian Health Service shall— 
(1) update and finalize the initial report under 
subsection (e); and 
(2) submit such final report to the committees 
specified in such subsection. 
(h) DEFINITIONS.—In this section: 
(1) The terms ‘‘Indian Tribe’’ and ‘‘Tribal or-
ganization’’ have the meanings given to such terms 
in section 4 of the Indian Self-Determination and 
Education Assistance Act (25 U.S.C. 5304). 
(2) The term ‘‘Urban Indian organization’’ has 
the meaning given to such term in section 4 of the 
Indian Health Care Improvement Act (25 U.S.C. 
1603).
585 
(i) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$25,000,000, to remain available until expended. 
SEC. 30576. CDC FIELD STUDIES PERTAINING TO SPECIFIC 
HEALTH INEQUITIES. 
(a) IN GENERAL.—Not later than 90 days after the 
date of enactment of this Act, the Secretary, acting 
through the Centers for Disease Control and Prevention, 
in collaboration with State, local, and territorial health de-
partments, shall complete (by the reporting deadline in 
subsection (b)) field studies to better understand health 
inequities that are not currently tracked by the Secretary. 
Such studies shall include an analysis of— 
(1) the impact of socioeconomic status on 
health care access and disease outcomes, including 
COVID–19 outcomes; 
(2) the impact of disability status on health 
care access and disease outcomes, including COVID– 
19 outcomes; 
(3) the impact of language preference on health 
care access and disease outcomes, including COVID– 
19 outcomes; 
(4) factors contributing to disparities in health 
outcomes for the COVID–19 pandemic; and
586 
(5) other topics related to disparities in health 
outcomes for the COVID–19 pandemic, as deter-
mined by the Secretary. 
(b) REPORT.—Not later than December 31, 2021, 
the Secretary shall submit to the Committee on Energy 
and Commerce of the House of Representatives and the 
Committee on Health, Education, Labor and Pensions of 
the Senate an initial report on the results of the field stud-
ies under this section. 
(c) FINAL REPORT.—Not later than December 31, 
2023, the Secretary shall— 
(1) update and finalize the initial report under 
subsection (b); and 
(2) submit such final report to the committees 
specified in such subsection. 
(d) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$25,000,000, to remain available until expended. 
SEC. 30577. ADDITIONAL REPORTING TO CONGRESS ON 
THE RACE AND ETHNICITY RATES OF COVID– 
19 TESTING, HOSPITALIZATIONS, AND MOR-
TALITIES. 
(a) IN GENERAL.—Not later than August 1, 2020, 
the Secretary shall submit to the Committee on Appro-
priations and the Committee on Energy and Commerce
587 
of the House of Representatives and the Committee on 
Appropriations and the Committee on Health, Education, 
Labor and Pensions of the Senate an initial report— 
(1) describing the testing, positive diagnoses, 
hospitalization, intensive care admissions, and mor-
tality 
rates 
associated 
with 
COVID–19, 
disaggregated by race, ethnicity, age, sex, gender, 
geographic region, and other relevant factors as de-
termined by the Secretary; 
(2) including an analysis of any variances of 
testing, positive diagnoses, hospitalizations, and 
deaths by demographic characteristics; and 
(3) including proposals for evidenced-based re-
sponse strategies to reduce disparities related to 
COVID–19. 
(b) FINAL REPORT.—Not later than December 31, 
2024, the Secretary shall— 
(1) update and finalize the initial report under 
subsection (a); and 
(2) submit such final report to the committees 
specified in such subsection. 
(c) COORDINATION.—In preparing the report sub-
mitted under this section, the Secretary shall take into ac-
count and otherwise coordinate such report with reporting 
required under section 30572 and under the heading ‘‘De-
588 
partment of Health and Human Services—Office of the 
Secretary—Public Health and Social Service Emergency 
Fund’’ in title I of division B of the Paycheck Protection 
Program and Health Care Enhancement Act (Public Law 
116–139; 134 Stat. 620, 626). 
Subtitle F—Miscellaneous 
SEC. 30581. TECHNICAL CORRECTIONS TO AMENDMENTS 
MADE BY CARES ACT. 
(a) The amendments made by this section shall take 
effect as if included in the enactment of the CARES Act 
(Public Law 116–136). 
(b) Section 3112 of division A of the CARES Act 
(Public Law 116–136) is amended— 
(1) in subsection (a)(2)(A), by striking the 
comma before ‘‘or a permanent’’; 
(2) in subsection (d)(1), by striking ‘‘and sub-
paragraphs (A) and (B)’’ and inserting ‘‘as subpara-
graphs (A) and (B)’’; and 
(3) in subsection (e), by striking ‘‘Drug, Cos-
metic Act’’ and inserting ‘‘Drug, and Cosmetic Act’’. 
(c) Section 6001(a)(1)(D) of division F of the Fami-
lies First Coronavirus Response Act (Public Law 116– 
127), as amended by section 3201 of division A of the 
CARES Act (Public Law 116–136), is amended by strik-
ing ‘‘other test that’’.
589 
(d) Subsection (k)(9) of section 543 of the Public 
Health Service Act (42 U.S.C. 290dd–2), as added by sec-
tion 3221(d) of division A of the CARES Act (Public Law 
116–136), is amended by striking ‘‘unprotected health in-
formation’’ and inserting ‘‘unsecured protected health in-
formation’’. 
(e) Section 3401(2)(D) of division A of the CARES 
Act (Public Law 116–136), is amended by striking ‘‘Not 
Later than’’ and inserting ‘‘Not later than’’. 
(f) Section 831(f) of the Public Health Service Act, 
as redesignated by section 3404(a)(6)(E) and amended by 
section 3404(a)(6)(G) of division A of the CARES Act 
(Public Law 116–136), is amended by striking ‘‘a health 
care facility, or a partnership of such a school and facil-
ity’’. 
(g) Section 846(i) of the Public Health Service Act, 
as amended by section 3404(i)(8)(C) of division A of the 
CARES Act (Public Law 116–136), is amended by strik-
ing ‘‘871(b),,’’ and inserting ‘‘871(b),’’. 
(h) Section 3606(a)(1)(A) of division A of the 
CARES Act (Public Law 116–136) is amended by striking 
‘‘In general’’ and inserting ‘‘IN GENERAL’’. 
(i) Section 3856(b)(1) of division A of the CARES 
Act (Public Law 116–136) is amended to read as follows:
590 
‘‘(1) IN GENERAL.—Section 905(b)(4) of the 
FDA Reauthorization Act of 2017 (Public Law 115– 
52) is amended by striking ‘Section 744H(e)(2)(B) 
of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 379j–52(e)(2)(B))’ and inserting ‘Section 
744H(f)(2)(B) of the Federal Food, Drug, and Cos-
metic Act, as redesignated by section 403(c)(1) of 
this Act,’.’’. 
TITLE VI—PUBLIC HEALTH 
ASSISTANCE 
Subtitle A—Assistance to Providers 
and Health System 
SEC. 30611. HEALTH CARE PROVIDER RELIEF FUND. 
(a) IN GENERAL.—Not later than 7 days after the 
date of enactment of this Act, the Secretary, acting 
through the Administrator of the Health Resources and 
Services Administration, shall establish a program under 
which the Secretary shall reimburse, through grants or 
other mechanisms, eligible health care providers for eligi-
ble expenses or lost revenues occurring during calendar 
quarters beginning on or after January 1, 2020, to pre-
vent, prepare for, and respond to COVID–19, in an 
amount calculated under subsection (c). 
(b) QUARTERLY BASIS.—
591 
(1) SUBMISSION OF APPLICATIONS.—The Sec-
retary shall give applicants a period of 7 calendar 
days after the close of a quarter to submit applica-
tions under this section with respect to such quarter, 
except that the Secretary shall give applicants a pe-
riod of 7 calendar days after the date of enactment 
of this Act to submit applications with respect to the 
quarter beginning on January 1, 2020, if the appli-
cant has not previously submitted an application 
with the respect to such quarter. 
(2) REVIEW
AND
PAYMENT.—The Secretary 
shall— 
(A) review applications and make awards 
of reimbursement under this section on a quar-
terly basis; and 
(B) award the reimbursements under this 
section for a quarter not later than 14 calendar 
days after the close of the quarter, except that 
the Secretary shall award the reimbursements 
under this section for the quarter beginning on 
January 1, 2020, not later than 14 calendar 
days after the date of enactment of this Act. 
(c) CALCULATION.— 
(1) IN
GENERAL.—The amount of the reim-
bursement to an eligible health care provider under
592 
this section with respect to a calendar quarter shall 
equal— 
(A) the sum of— 
(i) 100 percent of the eligible ex-
penses, as described in subsection (d), of 
the provider during the quarter; and 
(ii) subject to paragraph (3), 60 per-
cent of the lost revenues, as described in 
subsection (e), of the provider during the 
quarter; less 
(B) any funds that are— 
(i) received by the provider during the 
quarter pursuant to the Coronavirus Pre-
paredness and Response Supplemental Ap-
propriations Act, 2020 (Public Law 116– 
123), the Families First Coronavirus Re-
sponse Act (Public Law 116–127), the 
CARES Act (Public Law 116–136), or the 
Paycheck Protection Program and Health 
Care Enhancement Act (Public Law 116– 
139); and 
(ii) not required to be repaid. 
(2) CARRYOVER.—If the amount determined 
under paragraph (1)(B) for a calendar quarter with 
respect to an eligible health care provider exceeds
593 
the amount determined under paragraph (1)(A) with 
respect to such provider and quarter, the amount of 
such difference shall be applied in making the cal-
culation under this subsection, over each subsequent 
calendar quarter for which the eligible health care 
provider seeks reimbursement under this section. 
(3) 
LOST
REVENUE
LIMITATION.—If 
the 
amount determined under subsection (e) with re-
spect to the lost revenue of an eligible health care 
provider for a calendar quarter does not exceed an 
amount that equals 10 percent of the net patient 
revenue (as defined in such subsection) of the pro-
vider for the corresponding quarter in 2019, the ad-
dend under paragraph (1)(A)(ii), in making the cal-
culation under paragraph (1), is deemed to be zero. 
(d) ELIGIBLE EXPENSES.—Subject to subsection 
(h)(1), expenses eligible for reimbursement under this sec-
tion include expenses for— 
(1) building or construction of temporary struc-
tures; 
(2) leasing of properties; 
(3) medical supplies and equipment including 
personal protective equipment; 
(4) in vitro diagnostic tests, serological tests, or 
testing supplies;
594 
(5) increased workforce and trainings; 
(6) emergency operation centers; 
(7) construction or retrofitting of facilities; 
(8) mobile testing units; 
(9) surge capacity; 
(10) retention of workforce; and 
(11) such other items and services as the Sec-
retary determines to be appropriate, in consultation 
with relevant stakeholders. 
(e) LOST REVENUES.— 
(1) IN GENERAL.—Subject to subsection (h)(1), 
for purposes of subsection (c)(1)(A)(ii), the lost rev-
enues of an eligible health care provider, with re-
spect to the calendar quarter involved, shall be equal 
to— 
(A) net patient revenue of the provider for 
the corresponding quarter in 2019 minus net 
patient revenue of the provider for such quar-
ter; less 
(B) the savings of the provider during the 
calendar quarter involved attributable to fore-
gone wages, payroll taxes, and benefits of per-
sonnel who were furloughed or laid off by the 
provider during that quarter.
595 
(2) NET
PATIENT
REVENUE
DEFINED.—For 
purposes of paragraph (1)(A), the term ‘‘net patient 
revenue’’, with respect to an eligible health care pro-
vider and a calendar quarter, means the sum of— 
(A) 200 percent of the total amount of re-
imbursement received by the provider during 
the quarter for all items and services furnished 
under a State plan or a waiver of a State plan 
under title XIX of the Social Security Act (42 
U.S.C. 1396 et seq.); 
(B) 125 percent of the total amount of re-
imbursement received by the provider during 
the quarter for all items and services furnished 
under title XVIII of the Social Security Act (42 
U.S.C. 1395 et seq.); and 
(C) 100 percent of the total amount of re-
imbursement not described in subparagraph (A) 
or (B) received by the provider during the quar-
ter for all items and services. 
(f) INSUFFICIENT FUNDS FOR A QUARTER.—If there 
are insufficient funds made available to reimburse all eligi-
ble health care providers for all eligible expenses and lost 
revenues for a quarter in accordance with this section, the 
Secretary shall—
596 
(1) prioritize reimbursement of eligible ex-
penses; and 
(2) using the entirety of the remaining funds, 
uniformly reduce the percentage of lost revenues 
otherwise applicable under subsection (c)(1)(A)(ii) to 
the extent necessary to reimburse a portion of the 
lost revenues of all eligible health care providers ap-
plying for reimbursement. 
(g) APPLICATION.—A health care provider seeking 
reimbursement under this section for a calendar quarter 
shall submit to the Secretary an application that— 
(1) provides documentation demonstrating that 
the health care provider is an eligible health care 
provider; 
(2) includes a valid tax identification number of 
the health care provider or, if the health care pro-
vider does not have a valid tax identification num-
ber, an employer identification number or such other 
identification number as the Secretary may accept or 
may assign; 
(3) attests to the eligible expenses and lost rev-
enues of the health care provider, as described in 
subsection (d), occurring during the calendar quar-
ter;
597 
(4) includes an itemized listing of each such eli-
gible expense, including expenses incurred in pro-
viding uncompensated care; 
(5) for purposes of subsection (c)(3), attests to 
whether the amount determined under subsection (e) 
with respect to the lost revenue of an eligible health 
care provider for a calendar quarter exceeds an 
amount that equals 10 percent of the net patient 
revenue (as defined in such subsection) of the pro-
vider for the corresponding quarter in 2019; 
(6) includes projections of the eligible expenses 
and lost revenues of the health care provider, as de-
scribed in subsection (c), for the calendar quarter 
that immediately follows the calendar quarter for 
which reimbursement is sought; and 
(7) indicates the dollar amounts described in 
each of subparagraphs (A) and (B) of subsection 
(e)(1) and subparagraphs (A), (B), and (C) of sub-
section (e)(2) for the calendar quarter and any other 
information the Secretary determines necessary to 
determine expenses and lost revenue related to 
COVID–19. 
(h) LIMITATIONS.— 
(1) NO
DUPLICATIVE
REIMBURSEMENT.—The 
Secretary may not provide, and a health care pro-
598 
vider may not accept, reimbursement under this sec-
tion for expenses or losses with respect to which— 
(A) the eligible health care provider is re-
imbursed from other sources; or 
(B) other sources are obligated to reim-
burse the provider. 
(2) NO
EXECUTIVE
COMPENSATION.—Reim-
bursement for eligible expenses (as described in sub-
section (d)) and lost revenues (as described in sub-
section (e)) shall not include compensation or bene-
fits, including salary, bonuses, awards of stock, or 
other financial benefits, for an officer or employee 
described in section 4004(a)(2) of the CARES Act 
(Public Law 116–136). 
(i) NO BALANCE BILLING AS CONDITION OF RE-
CEIPT OF FUNDS.— 
(1) PROTECTING
INDIVIDUALS
ENROLLED
IN 
HEALTH PLANS.—As a condition of receipt of reim-
bursement under this section, a health care provider, 
in the case such provider furnishes during the emer-
gency period described in section 1135(g)(1)(B) of 
the Social Security Act (42 U.S.C. 1320b– 
5(g)(1)(B)) (whether before, on, or after, the date 
on which the provider submits an application under 
this section) a medically necessary item or service
602 
(4) PRESUMPTIVE
CASE
OF
COVID–19.—For 
purposes of paragraph (3)(B), an individual shall be 
presumed to have COVID–19 if the medical record 
documentation of the individual supports a diagnosis 
of COVID–19, even if the individual does not have 
a positive in vitro diagnostic test result in the med-
ical record of the individual. 
(5) PENALTY.—In the case of an eligible health 
care provider that is paid a reimbursement under 
this section and that is in violation of paragraph (1) 
or (2), in addition to any other penalties that may 
be prescribed by law, the Secretary may recoup from 
such provider up to the full amount of reimburse-
ment the provider receives under this section. 
(6) DEFINITIONS.—In this subsection: 
(A) NONPARTICIPATING
PROVIDER.—The 
term ‘‘nonparticipating provider’’ means, with 
respect to an item or service and group health 
plan or group or individual health insurance 
coverage offered by a health insurance issuer, a 
health care provider that does not have a con-
tractual relationship directly or indirectly with 
the plan or issuer, respectively, for furnishing 
such an item or service under the plan or cov-
erage.
603 
(B) PARTICIPATING PROVIDER.—The term 
‘‘participating provider’’ means, with respect to 
an item or service and group health plan or 
group or individual health insurance coverage 
offered by a health insurance issuer, a health 
care provider that has a contractual relation-
ship directly or indirectly with the plan or 
issuer, respectively, for furnishing such an item 
or service under the plan or coverage. 
(C) GROUP HEALTH PLAN, HEALTH INSUR-
ANCE
COVERAGE.—The terms ‘‘group health 
plan’’, ‘‘health insurance issuer’’, ‘‘group health 
insurance coverage’’, and ‘‘individual health in-
surance coverage’’ shall have the meanings 
given such terms under section 2791 of the 
Public Health Service Act (42 U.S.C. 300gg– 
91). 
(j) REPORTS.— 
(1) AWARD INFORMATION.—In making awards 
under this section, the Secretary shall post in a 
searchable, electronic format, a list of all recipients 
and awards pursuant to funding authorized under 
this section. 
(2) REPORTS BY RECIPIENTS.—Each recipient 
of an award under this section shall, as a condition
604 
on receipt of such award, submit reports and main-
tain documentation, in such form, at such time, and 
containing such information, as the Secretary deter-
mines is needed to ensure compliance with this sec-
tion. 
(3) PUBLIC
LISTING
OF
AWARDS.—The Sec-
retary shall— 
(A) not later than 7 days after the date of 
enactment of this Act, post in a searchable, 
electronic format, a list of all awards made by 
the Secretary under this section, including the 
recipients and amounts of such awards; and 
(B) update such list not less than every 7 
days until all funds made available to carry out 
this section are expended. 
(4) INSPECTOR GENERAL REPORT.— 
(A) IN GENERAL.—Not later than 3 years 
after final payments are made under this sec-
tion, the Inspector General of the Department 
of Health and Human Services shall transmit a 
final report on audit findings with respect to 
the program under this section to the Com-
mittee on Energy and Commerce and the Com-
mittee on Appropriations of the House of Rep-
resentatives and the Committee on Health,
605 
Education, Labor and Pensions and the Com-
mittee on Appropriations of the Senate. 
(B) RULE OF CONSTRUCTION.—Nothing in 
this paragraph shall be construed as limiting 
the authority of the Inspector General of the 
Department of Health and Human Services or 
the Comptroller General of the United States to 
conduct audits of interim payments earlier than 
the deadline described in subparagraph (A). 
(k) ELIGIBLE HEALTH CARE PROVIDER DEFINED.— 
In this section: 
(1) IN
GENERAL.—The term ‘‘eligible health 
care provider’’ means a health care provider de-
scribed in paragraph (2) that provides diagnostic or 
testing services or treatment to individuals with a 
confirmed or possible diagnosis of COVID–19. 
(2) HEALTH CARE PROVIDERS DESCRIBED.—A 
health care provider described in this paragraph is 
any of the following: 
(A) A health care provider enrolled as a 
participating provider under a State plan ap-
proved under title XIX of the Social Security 
Act (42 U.S.C. 1396 et seq.) (or a waiver of 
such a plan).
606 
(B) A provider of services (as defined in 
subsection (u) of section 1861 of the Social Se-
curity Act (42 U.S.C. 1395x)) or a supplier (as 
defined in subsection (d) of such section) that 
is enrolled as a participating provider of serv-
ices or participating supplier under the Medi-
care program under title XVIII of such Act (42 
U.S.C. 1395 et seq.). 
(C) A public entity. 
(D) Any other entity not described in this 
paragraph as the Secretary may specify. 
(l) FUNDING.— 
(1) AUTHORIZATION
OF
APPROPRIATIONS.— 
There is authorized to be appropriated for an addi-
tional 
amount 
to 
carry 
out 
this 
section 
$100,000,000,000, to remain available until ex-
pended. 
(2) HEALTH CARE PROVIDER RELIEF FUND.— 
(A) USE OF APPROPRIATED FUNDS.— 
(i) IN
GENERAL.—In addition to 
amounts authorized to be appropriated 
pursuant to paragraph (1), the unobligated 
balance of all amounts appropriated to the 
Health Care Provider Relief Fund shall be
607 
made available only to carry out this sec-
tion. 
(ii) 
AMOUNTS.—For 
purposes 
of 
clause (i), the following amounts are 
deemed to be appropriated to the Health 
Care Provider Relief Fund: 
(I) The unobligated balance of 
the 
appropriation 
of 
$100,000,000,000 in the third para-
graph under the heading ‘‘Depart-
ment of Health and Human Serv-
ices—Office of the Secretary—Public 
Health and Social Services Emergency 
Fund’’ in division B of the CARES 
Act (Public Law 116–136). 
(II) The unobligated balance of 
the appropriation under the heading 
‘‘Department of Health and Human 
Services—Office of the Secretary— 
Public Health and Social Services 
Emergency Fund’’ in division B of the 
Paycheck Protection Program and 
Health Care Enhancement Act (Pub-
lic Law 116–139).
608 
(B) LIMITATION.—Of the unobligated bal-
ances described in subparagraph (A)(ii), the 
Secretary may not make available more than 
$10,000,000,000 to reimburse eligible health 
care providers for expenses incurred in pro-
viding uncompensated care. 
(C) FUTURE
AMOUNTS.—Any appropria-
tion enacted subsequent to the date of enact-
ment of this Act that is made available for re-
imbursing eligible health care providers as de-
scribed in subsection (a) shall be made available 
only to carry out this section. 
SEC. 30612. PUBLIC HEALTH WORKFORCE LOAN REPAY-
MENT PROGRAM. 
Part D of title III of the Public Health Service Act 
(42 U.S.C. 254b et seq.) is amended by adding at the end 
the following new subpart: 
‘‘Subpart XIII—Public Health Workforce 
‘‘SEC. 340J. LOAN REPAYMENT PROGRAM. 
‘‘(a) ESTABLISHMENT.—The Secretary of Health 
and Human Services shall establish a program to be 
known as the Public Health Workforce Loan Repayment 
Program (referred to in this section as the ‘Program’) to 
assure an adequate supply of and encourage recruitment 
of public health professionals to eliminate critical public
609 
health workforce shortages in local, State, territorial, and 
Tribal public health agencies. 
‘‘(b) ELIGIBILITY.—To be eligible to participate in 
the Program, an individual shall— 
‘‘(1)(A) be accepted for enrollment, or be en-
rolled, as a student in an accredited academic edu-
cational institution in a State or territory in the 
final semester or equivalent of a course of study or 
program leading to a public health degree, a health 
professions degree or certificate, or a degree in com-
puter science, information science, information sys-
tems, information technology, or statistics and have 
accepted employment with a local, State, territorial, 
or Tribal public health agency, or a related training 
fellowship, as recognized by the Secretary, to com-
mence upon graduation; or 
‘‘(B)(i) have graduated, during the preceding 
10-year period, from an accredited educational insti-
tution in a State or territory and received a public 
health degree, a health professions degree or certifi-
cate, or a degree in computer science, information 
science, information systems, information tech-
nology, or statistics; and 
‘‘(ii) be employed by, or have accepted employ-
ment with, a local, State, territorial, or Tribal public
610 
health agency or a related training fellowship, as 
recognized by the Secretary; 
‘‘(2) be a United States citizen; 
‘‘(3)(A) submit an application to the Secretary 
to participate in the Program; and 
‘‘(B) execute a written contract as required in 
subsection (c); and 
‘‘(4) not have received, for the same service, a 
reduction of loan obligations under section 428K or 
428L of the Higher Education Act of 1965 (20 
U.S.C. 1078–11, 1078–12). 
‘‘(c) CONTRACT.—The written contract referred to in 
subsection (b)(3)(B) between the Secretary and an indi-
vidual shall contain— 
‘‘(1) an agreement on the part of the Secretary 
that the Secretary will repay, on behalf of the indi-
vidual, loans incurred by the individual in the pur-
suit of the relevant degree or certificate in accord-
ance with the terms of the contract; 
‘‘(2) an agreement on the part of the individual 
that the individual will serve in the full-time employ-
ment of a local, State, or Tribal public health agency 
or a related fellowship program in a position related 
to the course of study or program for which the con-
611 
tract was awarded for a period of time equal to the 
greater of— 
‘‘(A) 2 years; or 
‘‘(B) such longer period of time as deter-
mined appropriate by the Secretary and the in-
dividual; 
‘‘(3) an agreement, as appropriate, on the part 
of the individual to relocate to a priority service area 
(as determined by the Secretary) in exchange for an 
additional loan repayment incentive amount to be 
determined by the Secretary; 
‘‘(4) a provision that any financial obligation of 
the United States arising out of a contract entered 
into under this section and any obligation of the in-
dividual that is conditioned thereon, is contingent on 
funds being appropriated for loan repayments under 
this section; 
‘‘(5) a statement of the damages to which the 
United States is entitled, under this section for the 
individual’s breach of the contract; and 
‘‘(6) such other statements of the rights and li-
abilities of the Secretary and of the individual as the 
Secretary determines appropriate, not inconsistent 
with this section. 
‘‘(d) PAYMENTS.—
612 
‘‘(1) IN GENERAL.—A loan repayment provided 
for an individual under a written contract referred 
to in subsection (b)(3)(B) shall consist of payment, 
in accordance with paragraph (2), for the individual 
toward the outstanding principal and interest on 
education loans incurred by the individual in the 
pursuit of the relevant degree in accordance with the 
terms of the contract. 
‘‘(2) EQUITABLE DISTRIBUTION.—In awarding 
contracts under this section, the Secretary shall en-
sure— 
‘‘(A) a certain percentage of contracts are 
awarded to individuals who are not already 
working in public health departments; 
‘‘(B) an equitable distribution of funds 
geographically; and 
‘‘(C) an equitable distribution among 
State, local, territorial, and Tribal public health 
departments. 
‘‘(3) PAYMENTS
FOR
YEARS
SERVED.—For 
each year of service that an individual contracts to 
serve pursuant to subsection (c)(2), the Secretary 
may pay not more than $35,000 on behalf of the in-
dividual for loans described in paragraph (1). With 
respect to participants under the Program whose
613 
total eligible loans are less than $105,000, the Sec-
retary shall pay an amount that does not exceed 1⁄3 
of the eligible loan balance for each year of such 
service of such individual. 
‘‘(4) TAX LIABILITY.—For purposes of the In-
ternal Revenue Code of 1986, a payment made 
under this section shall be treated in the same man-
ner as an amount received under section 338B(g) of 
this Act, as described in section 108(f)(4) of such 
Code. 
‘‘(e) POSTPONING OBLIGATED SERVICE.—With re-
spect to an individual receiving a degree or certificate from 
a health professions or other related school, the date of 
the initiation of the period of obligated service may be 
postponed as approved by the Secretary. 
‘‘(f) BREACH OF CONTRACT.—An individual who fails 
to comply with the contract entered into under subsection 
(c) shall be subject to the same financial penalties as pro-
vided for under section 338E of the Public Health Service 
Act (42 U.S.C. 254o) for breaches of loan repayment con-
tracts under section 338B of such Act (42 U.S.C. section 
254l–1). 
‘‘(g) DEFINITION.—For purposes of this section, the 
term ‘full-time’ means full-time as such term is used in 
section 455(m)(3) of the Higher Education Act of 1965.
614 
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section— 
‘‘(1) $100,000,000 for fiscal year 2020; and 
‘‘(2) $75,000,000 for fiscal year 2021.’’. 
SEC. 30613. EXPANDING CAPACITY FOR HEALTH OUT-
COMES. 
(a) IN GENERAL.—The Secretary, acting through the 
Administrator of the Health Resources and Services Ad-
ministration, shall award grants to eligible entities to de-
velop and expand the use of technology-enabled collabo-
rative learning and capacity building models to respond 
to ongoing and real-time learning, health care information 
sharing, and capacity building needs related to COVID– 
19. 
(b) ELIGIBLE ENTITIES.—To be eligible to receive a 
grant under this section, an entity shall have experience 
providing technology-enabled collaborative learning and 
capacity building health care services— 
(1) in rural areas, frontier areas, health profes-
sional shortage areas, or medically underserved area; 
or 
(2) to medically underserved populations or In-
dian Tribes.
615 
(c) USE OF FUNDS.—An eligible entity receiving a 
grant under this section shall use funds received through 
the grant— 
(1) to advance quality of care in response to 
COVID–19, with particular emphasis on rural and 
underserved areas and populations; 
(2) to protect medical personnel and first re-
sponders through sharing real-time learning through 
virtual communities of practice; 
(3) to improve patient outcomes for conditions 
affected or exacerbated by COVID–19, including im-
provement of care for patients with complex chronic 
conditions; and 
(4) to support rapid uptake by health care pro-
fessionals of emerging best practices and treatment 
protocols around COVID–19. 
(d) OPTIONAL ADDITIONAL USES OF FUNDS.—An 
eligible entity receiving a grant under this section may use 
funds received through the grant for— 
(1) equipment to support the use and expansion 
of technology-enabled collaborative learning and ca-
pacity building models, including hardware and soft-
ware that enables distance learning, health care pro-
vider support, and the secure exchange of electronic 
health information;
616 
(2) the participation of multidisciplinary expert 
team members to facilitate and lead technology-en-
abled collaborative learning sessions, and profes-
sionals and staff assisting in the development and 
execution of technology-enabled collaborative learn-
ing; 
(3) the development of instructional program-
ming and the training of health care providers and 
other professionals that provide or assist in the pro-
vision of services through technology-enabled collabo-
rative learning and capacity building models; and 
(4) other activities consistent with achieving the 
objectives of the grants awarded under this section. 
(e) TECHNOLOGY-ENABLED COLLABORATIVE LEARN-
ING AND CAPACITY BUILDING MODEL DEFINED.—In this 
section, the term ‘‘technology-enabled collaborative learn-
ing and capacity building model’’ has the meaning given 
that term in section 2(7) of the Expanding Capacity for 
Health Outcomes Act (Public Law 114–270; 130 Stat. 
1395). 
(f) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$20,000,000, to remain available until expended.
617 
SEC. 30614. ADDITIONAL FUNDING FOR MEDICAL RESERVE 
CORPS. 
Section 2813 of the Public Health Service Act (42 
U.S.C. 300hh–15) is amended by striking ‘‘$11,200,000 
for each of fiscal years 2019 through 2023’’ and inserting 
‘‘$31,200,000 for each of fiscal years 2020 and 2021 and 
$11,200,000 for each of fiscal years 2022 and 2023’’. 
SEC. 30615. GRANTS FOR SCHOOLS OF MEDICINE IN DI-
VERSE AND UNDERSERVED AREAS. 
Subpart II of part C of title VII of the Public Health 
Service Act is amended by inserting after section 749B 
of such Act (42 U.S.C. 293m) the following: 
‘‘SEC. 749C. SCHOOLS OF MEDICINE IN UNDERSERVED 
AREAS. 
‘‘(a) GRANTS.—The Secretary, acting through the 
Administrator of the Health Resources and Services Ad-
ministration, may award grants to institutions of higher 
education (including multiple institutions of higher edu-
cation applying jointly) for the establishment, improve-
ment, and expansion of an allopathic or osteopathic school 
of medicine, or a branch campus of an allopathic or osteo-
pathic school of medicine. 
‘‘(b) PRIORITY.—In selecting grant recipients under 
this section, the Secretary shall give priority to institutions 
of higher education that—
618 
‘‘(1) propose to use the grant for an allopathic 
or osteopathic school of medicine, or a branch cam-
pus of an allopathic or osteopathic school of medi-
cine, in a combined statistical area with fewer than 
200 actively practicing physicians per 100,000 resi-
dents according to the medical board (or boards) of 
the State (or States) involved; 
‘‘(2) have a curriculum that emphasizes care for 
diverse and underserved populations; or 
‘‘(3) are minority-serving institutions described 
in the list in section 371(a) of the Higher Education 
Act of 1965. 
‘‘(c) USE OF FUNDS.—The activities for which a 
grant under this section may be used include— 
‘‘(1) planning and constructing— 
‘‘(A) a new allopathic or osteopathic school 
of medicine in an area in which no other school 
is based; or 
‘‘(B) a branch campus of an allopathic or 
osteopathic school of medicine in an area in 
which no such school is based; 
‘‘(2) accreditation and planning activities for an 
allopathic or osteopathic school of medicine or 
branch campus;
619 
‘‘(3) hiring faculty and other staff to serve at 
an allopathic or osteopathic school of medicine or 
branch campus; 
‘‘(4) recruitment and enrollment of students at 
an allopathic or osteopathic school of medicine or 
branch campus; 
‘‘(5) supporting educational programs at an 
allopathic or osteopathic school of medicine or 
branch campus; 
‘‘(6) modernizing infrastructure or curriculum 
at an existing allopathic or osteopathic school of 
medicine or branch campus thereof; 
‘‘(7) expanding infrastructure or curriculum at 
existing an allopathic or osteopathic school of medi-
cine or branch campus; and 
‘‘(8) other activities that the Secretary deter-
mines further the development, improvement, and 
expansion of an allopathic or osteopathic school of 
medicine or branch campus thereof. 
‘‘(d) DEFINITIONS.—In this section: 
‘‘(1) The term ‘branch campus’ means a geo-
graphically separate site at least 100 miles from the 
main campus of a school of medicine where at least 
one student completes at least 60 percent of the stu-
620 
dent’s training leading to a degree of doctor of medi-
cine. 
‘‘(2) The term ‘institution of higher education’ 
has the meaning given to such term in section 
101(a) of the Higher Education Act of 1965. 
‘‘(e) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
priated $1,000,000,000, to remain available until ex-
pended.’’. 
SEC. 30616. GAO STUDY ON PUBLIC HEALTH WORKFORCE. 
(a) IN GENERAL.—The Comptroller General of the 
United States shall conduct a study on the public health 
workforce in the United States during the COVID–19 
pandemic. 
(b) TOPICS.—The study under subsection (a) shall 
address— 
(1) existing gaps in the Federal, State, local, 
Tribal, and territorial public health workforce, in-
cluding— 
(A) epidemiological and disease interven-
tion specialists needed during the pandemic for 
contact tracing, laboratory technicians nec-
essary for testing, community health workers 
for community supports and services, and other
621 
staff necessary for contact tracing, testing, or 
surveillance activities; and 
(B) other personnel needed during the 
COVID–19 pandemic; 
(2) challenges associated with the hiring, re-
cruitment, and retention of the Federal, State, local, 
Tribal, and territorial public health workforce; and 
(3) recommended steps the Federal Government 
should take to improve hiring, recruitment, and re-
tention of the public health workforce. 
(c) REPORT.—Not later than December 1, 2021, the 
Comptroller General shall submit to the Congress a report 
on the findings of the study conducted under this section. 
SEC. 30617. LONGITUDINAL STUDY ON THE IMPACT OF 
COVID–19 ON RECOVERED PATIENTS. 
Part A of title IV of the Public Health Service Act 
(42 U.S.C. 281 et seq.) is amended by adding at the end 
the following: 
‘‘SEC. 404O. LONGITUDINAL STUDY ON THE IMPACT OF 
COVID–19 ON RECOVERED PATIENTS. 
‘‘(a) IN GENERAL.—The Director of NIH, in con-
sultation with the Director of the Centers for Disease Con-
trol and Prevention, shall conduct a longitudinal study, 
over not less than 10 years, on the full impact of SARS–
622 
CoV–2 or COVID–19 on infected individuals, including 
both short-term and long-term health impacts. 
‘‘(b) TIMING.—The Director of NIH shall begin en-
rolling patients in the study under this section not later 
than 6 months after the date of enactment of this section. 
‘‘(c) REQUIREMENTS.—The study under this section 
shall— 
‘‘(1) be nationwide; 
‘‘(2) include diversity of enrollees to account for 
gender, 
age, 
race, 
ethnicity, 
geography, 
comorbidities, and underrepresented populations, in-
cluding pregnant and lactating women; 
‘‘(3) study individuals with COVID–19 who ex-
perienced mild symptoms, such individuals who expe-
rienced moderate symptoms, and such individuals 
who experienced severe symptoms; 
‘‘(4) monitor the health outcomes and symp-
toms of individuals with COVID–19, or who had 
prenatal exposure to SARS–CoV–2 or COVID–19, 
including lung capacity and function, and immune 
response, taking into account any pharmaceutical 
interventions such individuals may have received; 
‘‘(5) monitor the mental health outcomes of in-
dividuals with COVID–19, taking into account any 
interventions that affected mental health; and
623 
‘‘(6) monitor individuals enrolled in the study 
not less frequently than twice per year after the first 
year of the individual’s infection with SARS–CoV–2. 
‘‘(d) PUBLIC-PRIVATE RESEARCH NETWORK.—For 
purposes of carrying out the study under this section, the 
Director of NIH may develop a network of public-private 
research partners, provided that all research, including the 
research carried out through any such partner, is available 
publicly. 
‘‘(e) SUMMARIES
OF FINDINGS.—The Director of 
NIH shall make public a summary of findings under this 
section not less frequently than once every 3 months for 
the first 2 years of the study, and not less frequently than 
every 6 months thereafter. Such summaries may include 
information about how the findings of the study under this 
section compare with findings from research conducted 
abroad. 
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section 
$200,000,000, to remain available until expended.’’. 
SEC. 30618. RESEARCH ON THE MENTAL HEALTH IMPACT 
OF COVID–19. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the National Institute of Mental Health, shall
624 
conduct or support research on the mental health con-
sequences of SARS–CoV–2 or COVID–19. 
(b) USE OF FUNDS.—Research under subsection (a) 
may include the following: 
(1) Research on the mental health impact of 
SARS–CoV–2 or COVID–19 on health care pro-
viders, including— 
(A) traumatic stress; 
(B) psychological distress; and 
(C) psychiatric disorders. 
(2) Research on the impact of SARS–CoV–2 or 
COVID–19 stressors on mental health over time. 
(3) Research to strengthen the mental health 
response to SARS–CoV–2 or COVID–19, including 
adapting to and maintaining or providing additional 
services for new or increasing mental health needs. 
(4) Research on the reach, efficiency, effective-
ness, and quality of digital mental health interven-
tions. 
(5) Research on effectiveness of strategies for 
implementation and delivery of evidence-based men-
tal health interventions and services for underserved 
populations. 
(6) Research on suicide prevention.
625 
(c) RESEARCH COORDINATION.—The Secretary shall 
coordinate activities under this section with similar activi-
ties conducted by national research institutes and centers 
of the National Institutes of Health to the extent that 
such institutes and centers have responsibilities that are 
related to the mental health consequences of SARS–CoV– 
2 or COVID–19. 
(d) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$200,000,000, to remain available until expended. 
SEC. 30619. EMERGENCY MENTAL HEALTH AND SUBSTANCE 
USE TRAINING AND TECHNICAL ASSISTANCE 
CENTER. 
Subpart 3 of part B of title V of the Public Health 
Service Act (42 U.S.C. 290bb–31 et seq.) is amended by 
inserting after section 520A (42 U.S.C. 290bb–32) the fol-
lowing: 
‘‘SEC. 520B. EMERGENCY MENTAL HEALTH AND SUB-
STANCE USE TRAINING AND TECHNICAL AS-
SISTANCE CENTER. 
‘‘(a) 
ESTABLISHMENT.—The 
Secretary, 
acting 
through the Assistant Secretary, shall establish or operate 
a center to be known as the Emergency Mental Health 
and Substance Use Training and Technical Assistance
626 
Center (referred to in this section as the ‘Center’) to pro-
vide technical assistance and support— 
‘‘(1) to public or nonprofit entities seeking to 
establish or expand access to mental health and sub-
stance use prevention, treatment, and recovery sup-
port services, and increase awareness of such serv-
ices; and 
‘‘(2) to public health professionals, health care 
professionals and support staff, essential workers (as 
defined by a State, Tribe, locality, or territory), and 
members of the public to address the trauma, stress, 
and mental health needs associated with an emer-
gency period. 
‘‘(b) ASSISTANCE
AND SUPPORT.—The assistance 
and support provided under subsection (a) shall include 
assistance and support with respect to— 
‘‘(1) training on identifying signs of trauma, 
stress, and mental health needs; 
‘‘(2) providing accessible resources to assist in-
dividuals and families experiencing trauma, stress, 
or other mental health needs during and after an 
emergency period; 
‘‘(3) providing resources for substance use dis-
order prevention, treatment, and recovery designed
627 
to assist individuals and families during and after an 
emergency period; 
‘‘(4) the provision of language access services, 
including translation services, interpretation, or 
other such services for individuals with limited 
English speaking proficiency or people with disabil-
ities; and 
‘‘(5) evaluation and improvement, as necessary, 
of the effectiveness of such services provided by pub-
lic or nonprofit entities. 
‘‘(c) BEST PRACTICES.—The Center shall periodi-
cally issue best practices for use by organizations seeking 
to provide mental health services or substance use disorder 
prevention, treatment, or recovery services to individuals 
during and after an emergency period. 
‘‘(d) EMERGENCY PERIOD.—In this section, the term 
‘emergency period’ has the meaning given such term in 
section 1135(g)(1)(A) of the Social Security Act. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section 
$20,000,000 for each of fiscal years 2020 and 2021.’’. 
SEC. 30620. IMPORTANCE OF THE BLOOD AND PLASMA SUP-
PLY. 
(a) IN GENERAL.—Section 3226 of the CARES Act 
(Public Law 116–136) is amended—
628 
(1) in the section heading after ‘‘BLOOD’’ by 
inserting ‘‘AND PLASMA’’; and 
(2) by inserting after ‘‘blood’’ each time it ap-
pears ‘‘and plasma’’. 
(b) CONFORMING AMENDMENT.—The item relating 
to section 3226 in the table of contents in section 2 of 
the CARES Act (Public Law 116–136) is amended to read 
as follows: 
‘‘Sec. 3226. Importance of the blood and plasma supply.’’. 
Subtitle B—Assistance for 
Individuals and Families 
SEC. 30631. REIMBURSEMENT FOR ADDITIONAL HEALTH 
SERVICES RELATING TO CORONAVIRUS. 
Title V of division A of the Families First 
Coronavirus Response Act (Public Law 116–127) is 
amended under the heading ‘‘Department of Health and 
Human Services—Office of the Secretary—Public Health 
and Social Services Emergency Fund’’ by inserting ‘‘, or 
treatment related to SARS–CoV–2 or COVID–19 for un-
insured individuals’’ after ‘‘or visits described in para-
graph (2) of such section for uninsured individuals’’. 
SEC. 30632. CENTERS FOR DISEASE CONTROL AND PREVEN-
TION COVID–19 RESPONSE LINE. 
(a) IN GENERAL.—During the public health emer-
gency declared by the Secretary pursuant to section 319 
of the Public Health Service Act (42 U.S.C. 247d) on Jan-
629 
uary 31, 2020 with respect to COVID–19, the Secretary, 
acting through the Director of the Centers for Disease 
Control and Prevention, shall maintain a toll-free tele-
phone number to address public health queries, including 
questions concerning COVID–19. 
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$10,000,000, to remain available until expended. 
SEC. 30633. GRANTS TO ADDRESS SUBSTANCE USE DURING 
COVID–19. 
(a) IN GENERAL.—The Assistant Secretary for Men-
tal Health and Substance Use of the Department of 
Health and Human Services (in this section referred to 
as the ‘‘Assistant Secretary’’), in consultation with the Di-
rector of the Centers for Disease Control and Prevention, 
shall award grants to States, political subdivisions of 
States, Tribes, Tribal organizations, and community-based 
entities to address the harms of drug misuse, including 
by— 
(1) preventing and controlling the spread of in-
fectious diseases, such as HIV/AIDS and viral hepa-
titis, and the consequences of such diseases for indi-
viduals with substance use disorder;
630 
(2) connecting individuals at risk for or with a 
substance use disorder to overdose education, coun-
seling, and health education; or 
(3) encouraging such individuals to take steps 
to reduce the negative personal and public health 
impacts of substance use or misuse during the emer-
gency period. 
(b) CONSIDERATIONS.—In awarding grants under 
this section, the Assistant Secretary shall prioritize grants 
to applicants proposing to serve areas with— 
(1) a high proportion of people who meet cri-
teria for dependence on or abuse of illicit drugs who 
have not received any treatment; 
(2) high drug overdose death rates; 
(3) high telemedicine infrastructure needs; and 
(4) high behavioral health and substance use 
disorder workforce needs. 
(c) DEFINITION.—In this section, the term ‘‘emer-
gency period’’ has the meaning given to such term in sec-
tion 1135(g)(1)(B) of the Social Security Act (42 U.S.C. 
1320b–5(g)(1)(B))). 
(d) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$10,000,000, to remain available until expended.
631 
SEC. 30634. GRANTS TO SUPPORT INCREASED BEHAVIORAL 
HEALTH NEEDS DUE TO COVID–19. 
(a) IN GENERAL.—The Secretary, acting through the 
Assistant Secretary of Mental Health and Substance Use, 
shall award grants to States, political subdivisions of 
States, Indian Tribes and Tribal organizations, commu-
nity-based entities, and primary care and behavioral 
health organizations to address behavioral health needs 
caused by the public health emergency declared pursuant 
to section 319 of the Public Health Service Act (42 U.S.C. 
247d) with respect to COVID–19. 
(b) USE OF FUNDS.—An entity that receives a grant 
under subsection (a) may use funds received through such 
grant to— 
(1) increase behavioral health treatment and 
prevention capacity, including to— 
(A) promote coordination among local enti-
ties; 
(B) train the behavioral health workforce, 
relevant stakeholders, and community members; 
(C) upgrade technology to support effective 
delivery of health care services through tele-
health modalities; 
(D) purchase medical supplies and equip-
ment for behavioral health treatment entities 
and providers;
632 
(E) address surge capacity for behavioral 
health needs such as through mobile units; and 
(F) promote collaboration between primary 
care and mental health providers; and 
(2) support or enhance behavioral health serv-
ices, including— 
(A) emergency crisis intervention, includ-
ing mobile crisis units, 24/7 crisis call centers, 
and medically staffed crisis stabilization pro-
grams; 
(B) screening, assessment, diagnosis, and 
treatment; 
(C) mental health awareness trainings; 
(D) evidence-based suicide prevention; 
(E) evidence-based integrated care models; 
(F) community recovery supports; 
(G) outreach to underserved and minority 
communities; and 
(H) for front line health care workers. 
(c) PRIORITY.—The Secretary shall give priority to 
applicants proposing to serve areas with a high number 
of COVID–19 cases. 
(d) EVALUATION.—An entity that receives a grant 
under this section shall prepare and submit an evaluation 
to the Secretary at such time, in such manner, and con-
633 
taining such information as the Secretary may reasonably 
require, including— 
(1) an evaluation of activities carried out with 
funds received through the grant; and 
(2) a process and outcome evaluation. 
(e) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$50,000,000 for each of fiscal years 2020 and 2021, to 
remain available until expended. 
Subtitle C—Assistance to Tribes 
SEC. 30641. IMPROVING STATE, LOCAL, AND TRIBAL PUB-
LIC HEALTH SECURITY. 
Section 319C–1 of the Public Health Service Act (42 
U.S.C. 247d–3a) is amended— 
(1) in the section heading, by striking ‘‘AND 
LOCAL’’ and inserting ‘‘, LOCAL, AND TRIBAL’’; 
(2) in subsection (b)— 
(A) in paragraph (1)— 
(i) in subparagraph (B), by striking 
‘‘or’’ at the end; 
(ii) in subparagraph (C), by striking 
‘‘and’’ at the end and inserting ‘‘or’’; and 
(iii) by adding at the end the fol-
lowing:
634 
‘‘(D) be an Indian Tribe, Tribal organiza-
tion, or a consortium of Indian Tribes or Tribal 
organizations; and’’; and 
(B) in paragraph (2)— 
(i) in the matter preceding subpara-
graph (A), by inserting ‘‘, as applicable’’ 
after ‘‘including’’; 
(ii) in subparagraph (A)(viii)— 
(I) by inserting ‘‘and Tribal’’ 
after ‘‘with State’’; 
(II) by striking ‘‘(as defined in 
section 8101 of the Elementary and 
Secondary Education Act of 1965)’’ 
and inserting ‘‘and Tribal educational 
agencies (as defined in sections 8101 
and 6132, respectively, of the Elemen-
tary and Secondary Education Act of 
1965)’’; and 
(III) by inserting ‘‘and Tribal’’ 
after ‘‘and State’’; 
(iii) in subparagraph (G), by striking 
‘‘and tribal’’ and inserting ‘‘Tribal, and 
urban Indian organization’’; and
635 
(iv) in subparagraph (H), by inserting 
‘‘, Indian Tribes, and urban Indian organi-
zations’’ after ‘‘public health’’; 
(3) in subsection (e), by inserting ‘‘Indian 
Tribes, Tribal organizations, urban Indian organiza-
tions,’’ after ‘‘local emergency plans,’’; 
(4) in subsection (g)(1), by striking ‘‘tribal offi-
cials’’ and inserting ‘‘Tribal officials’’; 
(5) in subsection (h)— 
(A) in paragraph (1)(A)— 
(i) by striking ‘‘through 2023’’ and 
inserting ‘‘and 2020’’; and 
(ii) by inserting before the period ‘‘; 
and $690,000,000 for each of fiscal years 
2021 through 2023 for awards pursuant to 
paragraph (3) (subject to the authority of 
the Secretary to make awards pursuant to 
paragraphs (4) and (5)) and paragraph 
(8), of which not less than $5,000,000 
shall be reserved each fiscal year for 
awards under paragraph (8)’’; 
(B) in subsection (h)(2)(B), by striking 
‘‘tribal public’’ and inserting ‘‘Tribal public’’; 
(C) in the heading of paragraph (3), by in-
serting ‘‘FOR STATES’’ after ‘‘AMOUNT’’; and
636 
(D) by adding at the end the following: 
‘‘(8) TRIBAL ELIGIBLE ENTITIES.— 
‘‘(A) 
DETERMINATION
OF
FUNDING 
AMOUNT.— 
‘‘(i) IN
GENERAL.—The Secretary 
shall award at least 10 cooperative agree-
ments under this section, in amounts not 
less than the minimum amount determined 
under clause (ii), to eligible entities de-
scribed in subsection (b)(1)(D) that sub-
mits to the Secretary an application that 
meets the criteria of the Secretary for the 
receipt of such an award and that meets 
other reasonable implementation conditions 
established by the Secretary, in consulta-
tion with Indian Tribes, for such awards. 
If the Secretary receives more than 10 ap-
plications under this section from eligible 
entities described in subsection (b)(1)(D) 
that meet the criteria and conditions de-
scribed in the previous sentence, the Sec-
retary, in consultation with Indian Tribes, 
may make additional awards under this 
section to such entities.
637 
‘‘(ii) MINIMUM
AMOUNT.—In deter-
mining the minimum amount of an award 
pursuant to clause (i), the Secretary, in 
consultation with Indian Tribes, shall first 
determine an amount the Secretary con-
siders appropriate for the eligible entity. 
‘‘(B) AVAILABLE
UNTIL
EXPENDED.— 
Amounts provided to a Tribal eligible entity 
under a cooperative agreement under this sec-
tion for a fiscal year and remaining unobligated 
at the end of such year shall remain available 
to such entity during the entirety of the per-
formance period, for the purposes for which 
said funds were provided. 
‘‘(C) NO MATCHING REQUIREMENT.—Sub-
paragraphs (B), (C), and (D) of paragraph (1) 
shall not apply with respect to cooperative 
agreements awarded under this section to eligi-
ble entities described in subsection (b)(1)(D).’’; 
and 
(6) by adding at the end the following: 
‘‘(l) SPECIAL RULES RELATED TO TRIBAL ELIGIBLE 
ENTITIES.— 
‘‘(1) MODIFICATIONS.—After consultation with 
Indian Tribes, the Secretary may make necessary
638 
and appropriate modifications to the program under 
this section to facilitate the use of the cooperative 
agreement program by eligible entities described in 
subsection (b)(1)(D). 
‘‘(2) WAIVERS.— 
‘‘(A) IN GENERAL.—Except as provided in 
subparagraph (B), the Secretary may waive or 
specify alternative requirements for any provi-
sion of this section (including regulations) that 
the Secretary administers in connection with 
this section if the Secretary finds that the waiv-
er or alternative requirement is necessary for 
the effective delivery and administration of this 
program with respect to eligible entities de-
scribed in subsection (b)(1)(D). 
‘‘(B) EXCEPTION.—The Secretary may not 
waive or specify alternative requirements under 
subparagraph (A) relating to labor standards or 
the environment. 
‘‘(3) CONSULTATION.—The Secretary shall con-
sult with Indian Tribes and Tribal organizations on 
the design of this program with respect to such 
Tribes and organizations to ensure the effectiveness 
of the program in enhancing the security of Indian 
Tribes with respect to public health emergencies.
639 
‘‘(4) REPORTING.— 
‘‘(A) IN GENERAL.—Not later than 2 years 
after the date of enactment of this subsection, 
and as an addendum to the biennial evaluations 
required under subsection (k), the Secretary, in 
coordination with the Director of the Indian 
Health Service, shall— 
‘‘(i) conduct a review of the implemen-
tation of this section with respect to eligi-
ble 
entities 
described 
in 
subsection 
(b)(1)(D), including any factors that may 
have limited its success; and 
‘‘(ii) submit a report describing the 
results of the review described in clause (i) 
to— 
‘‘(I) the Committee on Indian Af-
fairs, the Committee on Health, Edu-
cation, Labor and Pensions, and the 
Committee on Appropriations of the 
Senate; and 
‘‘(II) the Subcommittee for In-
digenous Peoples of the United States 
of the Committee on Natural Re-
sources, the Committee on Energy 
and Commerce, and the Committee on
640 
Appropriations of the House of Rep-
resentatives. 
‘‘(B) 
ANALYSIS
OF
TRIBAL
PUBLIC 
HEALTH
EMERGENCY
INFRASTRUCTURE
LIMI-
TATION.—The Secretary shall include in the 
initial report submitted under subparagraph (A) 
a description of any public health emergency in-
frastructure limitation encountered by eligible 
entities described in subsection (b)(1)(D).’’. 
SEC. 30642. PROVISION OF ITEMS TO INDIAN PROGRAMS 
AND FACILITIES. 
(a) STRATEGIC
NATIONAL
STOCKPILE.—Section 
319F–2(a)(3)(G) of the Public Health Service Act (42 
U.S.C. 247d–6b(a)(3)(G)) is amended by inserting ‘‘, and, 
in the case that the Secretary deploys the stockpile under 
this subparagraph, ensure, in coordination with the appli-
cable States and programs and facilities, that appropriate 
drugs, vaccines and other biological products, medical de-
vices, and other supplies are deployed by the Secretary di-
rectly to health programs or facilities operated by the In-
dian Health Service, an Indian Tribe, a Tribal organiza-
tion (as those terms are defined in section 4 of the Indian 
Self-Determination and Education Assistance Act (25 
U.S.C. 5304)), or an inter-Tribal consortium (as defined 
in section 501 of the Indian Self-Determination and Edu-
641 
cation Assistance Act (25 U.S.C. 5381)) or through an 
urban Indian organization (as defined in section 4 of the 
Indian Health Care Improvement Act), while avoiding du-
plicative distributions to such programs or facilities’’ be-
fore the semicolon. 
(b) DISTRIBUTION OF QUALIFIED PANDEMIC OR EPI-
DEMIC PRODUCTS TO IHS FACILITIES.—Title III of the 
Public Health Service Act (42 U.S.C. 241 et seq.) is 
amended by inserting after section 319F–4 the following: 
‘‘SEC. 319F–5. DISTRIBUTION OF QUALIFIED PANDEMIC OR 
EPIDEMIC PRODUCTS TO INDIAN PROGRAMS 
AND FACILITIES. 
‘‘In the case that the Secretary distributes qualified 
pandemic or epidemic products (as defined in section 
319F–3(i)(7)) to States or other entities, the Secretary 
shall ensure, in coordination with the applicable States 
and programs and facilities, that, as appropriate, such 
products are distributed directly to health programs or fa-
cilities operated by the Indian Health Service, an Indian 
Tribe, a Tribal organization (as those terms are defined 
in section 4 of the Indian Self-Determination and Edu-
cation Assistance Act (25 U.S.C. 5304)), or an inter-Trib-
al consortium (as defined in section 501 of the Indian 
Self-Determination and Education Assistance Act (25 
U.S.C. 5381)) or through an urban Indian organization
642 
(as defined in section 4 of the Indian Health Care Im-
provement Act), while avoiding duplicative distributions to 
such programs or facilities.’’. 
TITLE VII—OTHER MATTERS 
SEC. 30701. NON-DISCRIMINATION. 
(a) IN GENERAL.—Notwithstanding any provision of 
a covered law (or an amendment made in any such provi-
sion), no person otherwise eligible shall be excluded from 
participation in, denied the benefits of, or subjected to dis-
crimination in the administration of, programs and serv-
ices receiving funding under a covered law (or an amend-
ment made by a provision of such a covered law), based 
on any factor that is not merit-based, such as age, dis-
ability, sex (including sexual orientation, gender identity, 
and pregnancy, childbirth, and related medical condi-
tions), race, color, national origin, immigration status, or 
religion. 
(b) COVERED LAW DEFINED.—In this section, the 
term ‘‘covered law’’ includes— 
(1) this Act (other than this section); 
(2) title I of division B of the Paycheck Protec-
tion Program and Healthcare Enhancement Act 
(Public Law 116–139); 
(3) subtitles A, D, and E of title III of the 
CARES Act (Public Law 116–136);
643 
(4) division F of the Families First Coronavirus 
Relief Act (Public Law 116–127); and 
(5) division B of the Coronavirus Preparedness 
and Response Supplemental Appropriations Act, 
2020 (Public Law 116–123). 
DIVISION D—RETIREMENT 
PROVISIONS 
SEC. 40001. SHORT TITLE. 
This division may be cited as the ‘‘Emergency Pen-
sion Plan Relief Act of 2020’’. 
TITLE I—RELIEF FOR MULTIEM-
PLOYER PENSION PLANS 
SEC. 40101. SPECIAL PARTITION RELIEF. 
(a) APPROPRIATION.—Section 4005 of the Employee 
Retirement Income Security Act of 1974 (29 U.S.C. 1305) 
is amended by adding at the end the following: 
‘‘(i)(1) An eighth fund shall be established for parti-
tion assistance to multiemployer pension plans, as pro-
vided under section 4233A, and to pay for necessary ad-
ministrative and operating expenses relating to such as-
sistance. 
‘‘(2) There is appropriated from the general fund 
such amounts as necessary for the costs of providing parti-
tion assistance under section 4233A and necessary admin-
istrative and operating expenses. The eighth fund estab-
644 
lished under this subsection shall be credited with such 
amounts from time to time as the Secretary of the Treas-
ury determines appropriate, from the general fund of the 
Treasury, and such amounts shall remain available until 
expended.’’. 
(b) SPECIAL
PARTITION
AUTHORITY.—The Em-
ployee Retirement Income Security Act of 1974 (29 
U.S.C. 1001 et seq.) is amended by inserting after section 
4233 the following: 
‘‘SEC. 4233A. SPECIAL PARTITION RELIEF. 
‘‘(a) SPECIAL PARTITION AUTHORITY.— 
‘‘(1) IN GENERAL.—Upon the application of a 
plan sponsor of an eligible multiemployer plan for 
partition of the plan under this section, the corpora-
tion shall order a partition of the plan in accordance 
with this section. 
‘‘(2) INAPPLICABILITY OF CERTAIN REPAYMENT 
OBLIGATION.—A plan receiving partition assistance 
pursuant to this section shall not be subject to re-
payment obligations under section 4261(b)(2). 
‘‘(b) ELIGIBLE PLANS.— 
‘‘(1) IN GENERAL.—For purposes of this sec-
tion, a multiemployer plan is an eligible multiem-
ployer plan if—
647 
plications will be provided priority consider-
ation, if— 
‘‘(i) the plan is likely to become insol-
vent within 5 years of the date of enact-
ment of this section; 
‘‘(ii) the corporation projects a plan to 
have a present value of financial assistance 
payments under section 4261 that exceeds 
$1,000,000,000 if the special partition is 
not ordered; 
‘‘(iii) the plan has implemented ben-
efit suspensions under section 305(e)(9) as 
of the date of the enactment of this sec-
tion; or 
‘‘(iv) the corporation determines it ap-
propriate based on other circumstances. 
‘‘(B) NO EFFECT ON AMOUNT OF ASSIST-
ANCE.—A plan that is approved for special par-
tition assistance under this section shall not re-
ceive reduced special partition assistance on ac-
count of not receiving priority consideration 
under subparagraph (A). 
‘‘(3) ACTUARIAL ASSUMPTIONS AND OTHER IN-
FORMATION.—The corporation shall accept assump-
tions incorporated in a multiemployer plan’s deter-
648 
mination that it is in critical status or critical and 
declining status (within the meaning of section 
305(b)), or that the plan’s modified funded percent-
age is less than 40 percent, unless such assumptions 
are clearly erroneous. The corporation may require 
such other information as the corporation deter-
mines appropriate for making a determination of eli-
gibility and the amount of special partition assist-
ance necessary under this section. 
‘‘(4) APPLICATION DEADLINE.—Any application 
by a plan for special partition assistance under this 
section shall be submitted no later than December 
31, 2026, and any revised application for special 
partition assistance shall be submitted no later than 
December 31, 2027. 
‘‘(5) NOTICE OF APPLICATION.—Not later than 
120 days after the date of enactment of this section, 
the corporation shall issue guidance requiring multi-
employer plans to notify participants and bene-
ficiaries that the plan has applied for partition 
under this section, after the corporation has deter-
mined that the application is complete. Such notice 
shall reference the special partition relief internet 
website described in subsection (p).
649 
‘‘(d) DETERMINATIONS ON APPLICATIONS.—A plan’s 
application for special partition under this section that is 
timely filed in accordance with guidance issued under sub-
section (c)(1) shall be deemed approved and the corpora-
tion shall issue a special partition order unless the cor-
poration notifies the plan within 120 days of the filing 
of the application that the application is incomplete or the 
plan is not eligible under this section. Such notice shall 
specify the reasons the plan is ineligible for a special parti-
tion or information needed to complete the application. If 
a plan is denied partition under this subsection, the plan 
may submit a revised application under this section. Any 
revised application for special partition submitted by a 
plan shall be deemed approved unless the corporation noti-
fies the plan within 120 days of the filing of the revised 
application that the application is incomplete or the plan 
is not eligible under this section. A special partition order 
issued by the corporation shall be effective no later than 
120 days after a plan’s special partition application is ap-
proved by the corporation or deemed approved. 
‘‘(e) AMOUNT AND MANNER OF SPECIAL PARTITION 
ASSISTANCE.— 
‘‘(1) IN GENERAL.—The liabilities of an eligible 
multiemployer plan that the corporation assumes 
pursuant to a special partition order under this sec-
650 
tion shall be the amount necessary for the plan to 
meet its funding goals described in subsection (g). 
‘‘(2) NO CAP.—Liabilities assumed by the cor-
poration pursuant to a special partition order under 
this section shall not be capped by the guarantee 
under section 4022A. The corporation shall have dis-
cretion on how liabilities of the plan are partitioned. 
‘‘(f) SUCCESSOR PLAN.— 
‘‘(1) IN GENERAL.—The plan created by a spe-
cial partition order under this section is a successor 
plan to which section 4022A applies. 
‘‘(2) PLAN
SPONSOR
AND
ADMINISTRATOR.— 
The plan sponsor of an eligible multiemployer plan 
prior to the special partition and the administrator 
of such plan shall be the plan sponsor and the ad-
ministrator, respectively, of the plan created by the 
partition. 
‘‘(g) FUNDING GOALS.— 
‘‘(1) IN
GENERAL.—The funding goals of a 
multiemployer plan eligible for partition under this 
section are both of the following: 
‘‘(A) The plan will remain solvent over 30 
years with no reduction in a participant’s or 
beneficiary’s accrued benefit (except to the ex-
tent of a reduction in accordance with section
651 
305(e)(8) adopted prior to the plan’s applica-
tion for partition under this section). 
‘‘(B) The funded percentage of the plan 
(disregarding partitioned benefits) at the end of 
the 30-year period is projected to be 80 percent. 
‘‘(2) BASIS.—The funding projections under 
paragraph (1) shall be performed on a deterministic 
basis. 
‘‘(h) RESTORATION OF BENEFIT SUSPENSIONS.—An 
eligible multiemployer plan that is partitioned under this 
section shall— 
‘‘(1) reinstate any benefits that were suspended 
under section 305(e)(9) or section 4245(a), effective 
as of the first month the special partition order is 
effective, for participants or beneficiaries as of the 
effective date of the partition; and 
‘‘(2) provide payments equal to the amount of 
benefits previously suspended to any participants or 
beneficiaries in pay status as of the effective date of 
the special partition, payable in the form of a lump 
sum within 3 months of such effective date or in 
equal monthly installments over a period of 5 years, 
with no adjustment for interest. 
‘‘(i) ADJUSTMENT OF SPECIAL PARTITION ASSIST-
ANCE.—
652 
‘‘(1) IN GENERAL.—Every 5 years, the corpora-
tion shall adjust the special partition assistance de-
scribed in subsection (e) as necessary for the eligible 
multiemployer plan to satisfy the funding goals de-
scribed in subsection (g). If the 30 year period de-
scribed in subsection (g) has lapsed, in applying this 
paragraph, 5 years shall be substituted for 30 years. 
‘‘(2) SUBMISSION OF INFORMATION.—An eligi-
ble multiemployer plan that is the subject of a spe-
cial partition order under subsection (a) shall submit 
such information as the corporation may require to 
determine the amount of the adjustment under para-
graph (1). 
‘‘(3) CESSATION
OF
ADJUSTMENTS.—Adjust-
ments under this subsection with respect to special 
partition assistance for an eligible multiemployer 
plan shall cease and the corporation shall perma-
nently assume liability for payment of any benefits 
transferred to the successor plan (subject to sub-
section (l)) beginning with the first plan year that 
the funded percentage of the eligible multiemployer 
plan (disregarding partitioned benefits) is at least 
80 percent and the plan’s projected funded percent-
age for each of the next 10 years is at least 80 per-
cent. Any accumulated funding deficiency of the
653 
plan (within the meaning of section 304(a)) shall be 
reduced to zero as of the first day of the plan year 
for which partition assistance is permanent under 
this paragraph. 
‘‘(j) CONDITIONS ON PLANS DURING PARTITION.— 
‘‘(1) IN GENERAL.—The corporation may im-
pose, by regulation, reasonable conditions on an eli-
gible multiemployer plan that is partitioned under 
section (a) relating to increases in future accrual 
rates and any retroactive benefit improvements, allo-
cation of plan assets, reductions in employer con-
tribution rates, diversion of contributions to, and al-
location of, expenses to other retirement plans, and 
withdrawal liability. 
‘‘(2) LIMITATIONS.—The corporation shall not 
impose conditions on an eligible multiemployer plan 
as a condition of or following receipt of such parti-
tion assistance under this section relating to— 
‘‘(A) any reduction in plan benefits (in-
cluding benefits that may be adjusted pursuant 
to section 305(e)(8)); 
‘‘(B) plan governance, including selection 
of, removal of, and terms of contracts with, 
trustees, actuaries, investment managers, and 
other service providers; or
654 
‘‘(C) any funding rules relating to the plan 
that is partitioned under this section. 
‘‘(3) CONDITION.—An eligible multiemployer 
plan that is partitioned under subsection (a) shall 
continue to pay all premiums due under section 
4007 for participants and beneficiaries in the plan 
created by a special partition order until the plan 
year beginning after a cessation of adjustments ap-
plies under subsection (i). 
‘‘(k) WITHDRAWAL LIABILITY.—An employer’s with-
drawal liability for purposes of this title shall be calculated 
taking into account any plan liabilities that are partitioned 
under subsection (a) until the plan year beginning after 
the expiration of 15 calendar years from the effective date 
of the partition. 
‘‘(l) CESSATION OF PARTITION ASSISTANCE.—If a 
plan that receives partition assistance under this section 
becomes insolvent for purposes of section 418E of the In-
ternal Revenue Code of 1986, the plan shall no longer be 
eligible for assistance under this section and shall be eligi-
ble for assistance under section 4261. 
‘‘(m) REPORTING.—An eligible multiemployer plan 
that receives partition assistance under this section shall 
file with the corporation a report, including the following 
information, in such manner (which may include electronic
655 
filing requirements) and at such time as the corporation 
requires: 
‘‘(1) The funded percentage (as defined in sec-
tion 305(j)(2)) as of the first day of such plan year, 
and the underlying actuarial value of assets and li-
abilities taken into account in determining such per-
centage. 
‘‘(2) The market value of the assets of the plan 
(determined as provided in paragraph (1)) as of the 
last day of the plan year preceding such plan year. 
‘‘(3) The total value of all contributions made 
by employers and employees during the plan year 
preceding such plan year. 
‘‘(4) The total value of all benefits paid during 
the plan year preceding such plan year. 
‘‘(5) Cash flow projections for such plan year 
and the 9 succeeding plan years, and the assump-
tions used in making such projections. 
‘‘(6) Funding standard account projections for 
such plan year and the 9 succeeding plan years, and 
the assumptions relied upon in making such projec-
tions. 
‘‘(7) The total value of all investment gains or 
losses during the plan year preceding such plan year.
656 
‘‘(8) Any significant reduction in the number of 
active participants during the plan year preceding 
such plan year, and the reason for such reduction. 
‘‘(9) A list of employers that withdrew from the 
plan in the plan year preceding such plan year, the 
payment schedule with respect to such withdrawal li-
ability, and the resulting reduction in contributions. 
‘‘(10) A list of employers that paid withdrawal 
liability to the plan during the plan year preceding 
such plan year and, for each employer, a total as-
sessment of the withdrawal liability paid, the annual 
payment amount, and the number of years remain-
ing in the payment schedule with respect to such 
withdrawal liability. 
‘‘(11) Any material changes to benefits, accrual 
rates, or contribution rates during the plan year pre-
ceding such plan year, and whether such changes re-
late to the conditions of the partition assistance. 
‘‘(12) Details regarding any funding improve-
ment plan or rehabilitation plan and updates to such 
plan. 
‘‘(13) The number of participants and bene-
ficiaries during the plan year preceding such plan 
year who are active participants, the number of par-
ticipants and beneficiaries in pay status, and the
657 
number of terminated vested participants and bene-
ficiaries. 
‘‘(14) The information contained on the most 
recent annual funding notice submitted by the plan 
under section 101(f). 
‘‘(15) The information contained on the most 
recent annual return under section 6058 of the In-
ternal Revenue Code of 1986 and actuarial report 
under section 6059 of such Code of the plan. 
‘‘(16) Copies of the plan document and amend-
ments, other retirement benefit or ancillary benefit 
plans relating to the plan and contribution obliga-
tions under such plans, a breakdown of administra-
tive expenses of the plan, participant census data 
and distribution of benefits, the most recent actu-
arial valuation report as of the plan year, financial 
reports, and copies of the portions of collective bar-
gaining agreements relating to plan contributions, 
funding coverage, or benefits, and such other infor-
mation as the corporation may reasonably require. 
Any information disclosed by a plan to the corporation 
that could identify individual employers shall be confiden-
tial and not subject to publication or disclosure. 
‘‘(n) REPORT TO CONGRESS.—
658 
‘‘(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of this section and annually 
thereafter, the board of directors of the corporation 
shall submit to the Committee on Health, Edu-
cation, Labor, and Pensions and the Committee on 
Finance of the Senate and the Committee on Edu-
cation and Labor and the Committee on Ways and 
Means of the House of Representatives a detailed re-
port on the implementation and administration of 
this section. Such report shall include— 
‘‘(A) information on the name and number 
of multiemployer plans that have applied for 
partition assistance under this section; 
‘‘(B) the name and number of such plans 
that have been approved for partition assistance 
under this section and the name and number of 
the plans that have not been approved for spe-
cial partition assistance; 
‘‘(C) a detailed rationale for any decision 
by the corporation to not approve an applica-
tion for special partition assistance; 
‘‘(D) the amount of special partition as-
sistance provided to eligible multiemployer 
plans (including amounts provided on an indi-
vidual plan basis and in the aggregate);
659 
‘‘(E) the name and number of the multi-
employer plans that restored benefit suspen-
sions and provided lump sum or monthly in-
stallment payments to participants or bene-
ficiaries; 
‘‘(F) the amount of benefits that were re-
stored and lump sum or monthly installment 
payments that were paid (including amounts 
provided on an individual plan basis and in the 
aggregate); 
‘‘(G) the name and number of the plans 
that received adjustments to partition assist-
ance under subsection (i); 
‘‘(H) a list of, and rationale for, each rea-
sonable condition imposed by the corporation on 
plans approved for special partition assistance 
under this section; 
‘‘(I) the contracts that have been awarded 
by the corporation to implement or administer 
this section; 
‘‘(J) the number, purpose, and dollar 
amounts of the contracts that have been award-
ed to implement or administer the section; 
‘‘(K) a detailed summary of the reports re-
quired under subsection (m); and
660 
‘‘(L) a detailed summary of the feedback 
received on the pension relief internet website 
established under subsection (p). 
‘‘(2) PBGC CERTIFICATION.—The board of di-
rectors of the corporation shall include with the re-
port under paragraph (1) a certification and affir-
mation that the amount of special partition assist-
ance provided to each plan under this section is the 
amount necessary to meet its funding goals under 
subsection (g), including, if applicable, any adjust-
ment of special partition assistance as determined 
under subsection (i). 
‘‘(3) CONFIDENTIALITY.—Congress may pub-
licize the reports received under paragraph (1) only 
after redacting all sensitive or proprietary informa-
tion. 
‘‘(o) GAO REPORT.—Not later than 1 year after the 
first partition application is approved by the corporation 
under this section, and biennially thereafter, the Comp-
troller General of the United States shall submit to the 
Committee on Health, Education, Labor, and Pensions 
and the Committee on Finance of the Senate and the 
Committee on Education and Labor and the Committee 
on Ways and Means of the House of Representatives a 
detailed report on the actions of the corporation to imple-
661 
ment and administer this section, including an examina-
tion of the contracts awarded by such corporation to carry 
out this section and an analysis of such corporation’s com-
pliance with subsections (e) and (g). 
‘‘(p) SPECIAL PARTITION RELIEF WEBSITE.— 
‘‘(1) ESTABLISHMENT.—Not later than 120 
days after the date of enactment of this section, the 
corporation shall establish and maintain a user- 
friendly, public-facing internet website to foster 
greater accountability and transparency in the im-
plementation and administration of this section. 
‘‘(2) PURPOSE.—The internet website estab-
lished and maintained under paragraph (1) shall be 
a portal to key information relating to this section 
for multiemployer plan administrators and trustees, 
plan participants, beneficiaries, participating em-
ployers, other stakeholders, and the public. 
‘‘(3) CONTENT AND FUNCTION.—The internet 
website established under paragraph (1) shall— 
‘‘(A) describe the nature and scope of the 
special partition authority and assistance under 
this section in a manner calculated to be under-
stood by the average plan participant; 
‘‘(B) include published guidance, regula-
tions, and all other relevant information on the
662 
implementation and administration of this sec-
tion; 
‘‘(C) include, with respect to plan applica-
tions for special partition assistance— 
‘‘(i) a general description of the proc-
ess by which eligible plans can apply for 
special partition assistance, information on 
how and when the corporation will process 
and consider plan applications; 
‘‘(ii) information on how the corpora-
tion will address any incomplete applica-
tions as specified in under this section; 
‘‘(iii) a list of the plans that have ap-
plied for special partition assistance and, 
for each application, the date of submis-
sion of a completed application; 
‘‘(iv) the text of each plan’s completed 
application for special partition assistance 
with appropriate redactions of personal, 
proprietary, or sensitive information; 
‘‘(v) the estimated date that a deci-
sion will be made by the corporation on 
each application; 
‘‘(vi) the actual date when such deci-
sion is made;
663 
‘‘(vii) the corporation’s decision on 
each application; and 
‘‘(viii) as applicable, a detailed ration-
ale for any decision not to approve a plan’s 
application for special partition assistance; 
‘‘(D) provide detailed information on each 
contract solicited and awarded to implement or 
administer this section; 
‘‘(E) include reports, audits, and other rel-
evant oversight and accountability information 
on this section, including the annual reports 
submitted by the board of directors of the cor-
poration to Congress required under subsection 
(n), the Office of the Inspector General audits, 
correspondence, and publications, and the Gov-
ernment Accountability Office reports under 
subsection (o); 
‘‘(F) provide a clear means for multiem-
ployer plan administrators, plan participants, 
beneficiaries, other stakeholders, and the public 
to contact the corporation and provide feedback 
on the implementation and administration of 
this section; and 
‘‘(G) be regularly updated to carry out the 
purposes of this subsection.
681 
SEC. 40303. EMPLOYEE CERTIFICATION AS TO ELIGIBILITY 
FOR INCREASED CARES ACT LOAN LIMITS 
FROM EMPLOYER PLAN. 
(a) 
IN
GENERAL.—Section 
2202(b) 
of 
the 
Coronavirus Aid, Relief, and Economic Security Act is 
amended by adding at the end the following new para-
graph: 
‘‘(4) EMPLOYEE CERTIFICATION.—The admin-
istrator of a qualified employer plan may rely on an 
employee’s certification that the requirements of 
subsection (a)(4)(A)(ii) are satisfied in determining 
whether the employee is a qualified individual for 
purposes of this subsection.’’. 
(b) EFFECTIVE DATE.—The amendment made by 
this section shall take effect as if included in the enact-
ment of section 2202(b) of the Coronavirus Aid, Relief, 
and Economic Security Act. 
SEC. 40304. EXCLUSION OF BENEFITS PROVIDED TO VOL-
UNTEER FIREFIGHTERS AND EMERGENCY 
MEDICAL RESPONDERS MADE PERMANENT. 
(a) IN GENERAL.—Section 139B of the Internal Rev-
enue Code of 1986 is amended by striking subsection (d). 
(b) EFFECTIVE DATE.—The amendment made by 
this section shall apply to taxable years beginning after 
December 31, 2020.